<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">72923</article-id><article-id pub-id-type="doi">10.7554/eLife.72923</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>IL-4 and helminth infection downregulate MINCLE-dependent macrophage response to mycobacteria and Th17 adjuvanticity</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-249579"><name><surname>Schick</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-249574"><name><surname>Altunay</surname><given-names>Meltem</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-249573"><name><surname>Lacorcia</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-301693"><name><surname>Marschner</surname><given-names>Nathalie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301694"><name><surname>Westermann</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301695"><name><surname>Schluckebier</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249576"><name><surname>Schubart</surname><given-names>Christoph</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249575"><name><surname>Bodendorfer</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249577"><name><surname>Christensen</surname><given-names>Dennis</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249578"><name><surname>Alexander</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-111379"><name><surname>Wirtz</surname><given-names>Stefan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6936-7431</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157552"><name><surname>Voehringer</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6650-0639</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249580"><name><surname>da Costa</surname><given-names>Clarissa Prazeres</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-115337"><name><surname>Lang</surname><given-names>Roland</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0502-3677</contrib-id><email>roland.lang@uk-erlangen.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0030f2a11</institution-id><institution>Institut für Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg</institution></institution-wrap><addr-line><named-content content-type="city">Erlangen</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kkvpp62</institution-id><institution>Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Center for Global Health, Technische Universität München</institution></institution-wrap><addr-line><named-content content-type="city">Munich</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kkvpp62</institution-id><institution>Center for Global Health, Technical University Munich</institution></institution-wrap><addr-line><named-content content-type="city">Munich</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0030f2a11</institution-id><institution>Infektionsbiologische Abteilung, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg</institution></institution-wrap><addr-line><named-content content-type="city">Erlangen</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0417ye583</institution-id><institution>Adjuvant Research, Department of Infectious Disease Immunology, Statens Serum Institut</institution></institution-wrap><addr-line><named-content content-type="city">Copenhagen</named-content></addr-line><country>Denmark</country></aff><aff id="aff6"><label>6</label><institution>Cellular Microbiology, Forschungszentrum Borstel, Leibniz Lung Center Borstel</institution><addr-line><named-content content-type="city">Borstel</named-content></addr-line><country>Germany</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0030f2a11</institution-id><institution>Medizinische Klinik 1, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg</institution></institution-wrap><addr-line><named-content content-type="city">Erlangen</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Stallings</surname><given-names>Christina L</given-names></name><role>Reviewing Editor</role><aff><institution>Washington University School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>08</day><month>02</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e72923</elocation-id><history><date date-type="received" iso-8601-date="2021-08-09"><day>09</day><month>08</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2023-01-30"><day>30</day><month>01</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-08-19"><day>19</day><month>08</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.08.17.456702"/></event></pub-history><permissions><copyright-statement>© 2023, Schick et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Schick et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-72923-v1.pdf"/><abstract><p>The myeloid C-type lectin receptor (CLR) MINCLE senses the mycobacterial cell wall component trehalose-6,6’-dimycolate (TDM). Recently, we found that IL-4 downregulates MINCLE expression in macrophages. IL-4 is a hallmark cytokine in helminth infections, which appear to increase the risk for mycobacterial infection and active tuberculosis. Here, we investigated functional consequences of IL-4 and helminth infection on MINCLE-driven macrophage activation and Th1/Th17 adjuvanticity. IL-4 inhibited MINCLE and cytokine induction after macrophage infection with <italic>Mycobacterium bovis</italic> bacille Calmette-Guerin (BCG). Infection of mice with BCG upregulated MINCLE on myeloid cells, which was inhibited by IL-4 plasmid injection and by infection with the nematode <italic>Nippostrongylus brasiliensis</italic> in monocytes. To determine the impact of helminth infection on MINCLE-dependent immune responses, we vaccinated mice with a recombinant protein together with the MINCLE ligand trehalose-6,6-dibehenate (TDB) as adjuvant. Concurrent infection with <italic>N. brasiliensis</italic> or with <italic>Schistosoma mansoni</italic> promoted T cell-derived IL-4 production and suppressed Th1/Th17 differentiation in the spleen. In contrast, helminth infection did not reduce Th1/Th17 induction by TDB in draining peripheral lymph nodes, where IL-4 levels were unaltered. Upon use of the TLR4-dependent adjuvant G3D6A, <italic>N. brasiliensis</italic> infection impaired selectively the induction of splenic antigen-specific Th1 but not of Th17 cells. Inhibition of MINCLE-dependent Th1/Th17 responses in mice infected with <italic>N. brasiliensis</italic> was dependent on IL-4/IL-13. Thus, helminth infection attenuated the Th17 response to MINCLE-dependent immunization in an organ- and adjuvant-specific manner via the Th2 cytokines IL-4/IL-13. Taken together, our results demonstrate downregulation of MINCLE expression on monocytes and macrophages by IL-4 as a possible mechanism of thwarted Th17 vaccination responses by underlying helminth infection.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>co-infection</kwd><kwd>Th cell differentiation</kwd><kwd><italic>Nippostrongylus brasiliensis</italic></kwd><kwd><italic>Schistosoma mansoni</italic></kwd><kwd>mycobacterial cord factor</kwd><kwd>C-type lectin receptors</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>LA 1262/8-1</award-id><principal-award-recipient><name><surname>Lang</surname><given-names>Roland</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>CDC 1181_A02</award-id><principal-award-recipient><name><surname>Voehringer</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>CO 1469/16-1</award-id><principal-award-recipient><name><surname>da Costa</surname><given-names>Clarissa Prazeres</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The expression of DECTIN-2 family C-type lectin receptors on macrophages and monocytes is inhibited by the Th2 cytokine IL-4, which suggests a mechanism for inhibition of Th17 responses to MINCLE-dependent vaccination responses by underlying helminth infection.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Tuberculosis kills more than 1 million humans each year and is easily spread by aerosol infection. Importantly, after exposure to <italic>Mycobacterium tuberculosis</italic> (MTB) by inhalation, only a minority of contacts develops active pulmonary disease with mycobacterial replication and destruction of lung tissue. In the majority of exposed people, inhaled MTB is either killed by the innate immune system of the lung or triggers the development of granuloma structures around infected cells (<xref ref-type="bibr" rid="bib46">Pai et al., 2016</xref>). The development of specific CD4+ T cell responses then induces control of mycobacterial growth without achieving eradication of MTB, a status referred to as latency (<xref ref-type="bibr" rid="bib46">Pai et al., 2016</xref>). It is estimated that more than a quarter of the world’s population is latently infected with MTB. Their life-long risk to develop reactivation tuberculosis is around 5% and is influenced by a variety of genetic and environmental factors.</p><p>Parasitic helminth infections with intestinal nematodes, filaria, or trematodes affect an estimated number of &gt;2 billion humans (<xref ref-type="bibr" rid="bib7">Babu and Nutman, 2016</xref>). Similar to tuberculosis, helminth infections are often chronic and not acutely life-threatening. Epidemiologically, tuberculosis and helminth infections co-occur in many tropical and subtropical countries (<xref ref-type="bibr" rid="bib57">Salgame et al., 2013</xref>). Immune responses to helminths in general are characterized by a strong Th2 component with production of IL-4, IL-5, IL-13, IL-10, and IgE (<xref ref-type="bibr" rid="bib7">Babu and Nutman, 2016</xref>), whereas protective immunity to MTB requires robust Th1 immunity and is possibly enhanced by Th17 cells (<xref ref-type="bibr" rid="bib23">Gopal et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Monin et al., 2015</xref>). These diametrically opposed immunological biases and effector mechanisms raise the question how MTB and parasitic helminths mutually influence each other in co-infected individuals (<xref ref-type="bibr" rid="bib7">Babu and Nutman, 2016</xref>). Interestingly, helminth infection of household contacts of patients with active, smear-positive tuberculosis increased the rate of tuberculin skin test conversion indicating a higher risk to become infected (<xref ref-type="bibr" rid="bib69">Verhagen et al., 2012</xref>). Furthermore, active tuberculosis patients are more often co-infected with helminths than healthy counterparts (<xref ref-type="bibr" rid="bib16">Elias et al., 2006</xref>; <xref ref-type="bibr" rid="bib67">Tristão-Sá et al., 2002</xref>). Furthermore, helminth co-infection is associated with more advanced disease in tuberculosis patients and with reduced production of IFNγ but increased IL-10 (<xref ref-type="bibr" rid="bib53">Resende Co et al., 2007</xref>). These findings indicate that the type 2 immune bias in helminth-infected individuals can impair the development of protective adaptive immunity to MTB. In contrast, other studies showed that underlying helminth infection can promote a Th2 and regulatory T cell response to MTB with a reduced risk to develop open, smear-positive pulmonary tuberculosis (<xref ref-type="bibr" rid="bib1">Abate et al., 2015</xref>). In mice, infection with <italic>Nippostrongylus brasiliensis</italic> enhances bacterial load in the lung after MTB infection, an effect attributed to the action of alternatively activated macrophages (<xref ref-type="bibr" rid="bib49">Potian et al., 2011</xref>).</p><p>Underlying helminth infection may also influence the response to vaccination with <italic>Mycobacterium bovis</italic> bacille Calmette-Guerin (BCG), which shows large geographic variation with reduced efficacy in countries with a high prevalence of worm infections (<xref ref-type="bibr" rid="bib56">Roy et al., 2014</xref>; <xref ref-type="bibr" rid="bib11">Colditz et al., 1994</xref>). Experimental infection of mice with <italic>Schistosoma (S.) mansoni</italic> or <italic>Heligmosomoides (H.) polygyrus</italic> impaired Th1 cell generation after vaccination with BCG (<xref ref-type="bibr" rid="bib15">Elias et al., 2005</xref>; <xref ref-type="bibr" rid="bib43">Obieglo et al., 2016</xref>), although another study found that chronic enteric infection with <italic>H. polygyrus</italic> did not interfere with primary or memory T cell responses to BCG (<xref ref-type="bibr" rid="bib50">Rafi et al., 2015</xref>). Thus, these results from experimental mouse models show that not all helminth infections have a similarly strong impact on protective immunity to MTB. Anthelminthic treatment prior to BCG administration led to increased IFNγ and IL-12 production (<xref ref-type="bibr" rid="bib14">Elias et al., 2001</xref>). It is noteworthy that maternal helminth infection during pregnancy negatively affected the frequency of IFNγ-producing T cells in cord blood of neonates (<xref ref-type="bibr" rid="bib19">Gebreegziabiher et al., 2014</xref>) and the development of Th1 immunity in BCG-vaccinated offspring (<xref ref-type="bibr" rid="bib35">Malhotra et al., 1999</xref>). However, attempts to enhance the immunogenicity of BCG vaccination by anthelminthic treatment of mothers during pregnancy were not successful (<xref ref-type="bibr" rid="bib70">Webb et al., 2011</xref>).</p><p>Sensing of mycobacteria by the innate immune system is essential for a robust defense reaction, including the secretion of chemokines to attract leukocytes to the site of infection and the production of cytokines directing antigen-specific T cell responses toward Th1 and Th17 differentiation. Mycobacteria contain a plethora of PAMPs, for example, the TLR ligands 19 kDa lipoprotein, lipoarabinomannan (LAM), and mycobacterial DNA rich in CpG motifs (<xref ref-type="bibr" rid="bib41">Mortaz et al., 2015</xref>). The hydrophobic cell wall of mycobacteria is especially rich in the glycolipid trehalose-6,6’-dimycolate (TDM, <italic>aka</italic> the cord factor), which is sufficient to trigger granulomatous reactions in vivo (<xref ref-type="bibr" rid="bib28">Ishikawa et al., 2009</xref>), induces inflammatory cytokine production by macrophages (<xref ref-type="bibr" rid="bib21">Geisel et al., 2005</xref>), and confers the Th1/Th17 adjuvant activity known from Freund’s complete adjuvant (<xref ref-type="bibr" rid="bib62">Shenderov et al., 2013</xref>). TDM binds to the C-type lectin receptor (CLR) MINCLE (encoded by the <italic>Clec4e</italic> gene) (<xref ref-type="bibr" rid="bib28">Ishikawa et al., 2009</xref>; <xref ref-type="bibr" rid="bib60">Schoenen et al., 2010</xref>), which is inducibly expressed in macrophages (<xref ref-type="bibr" rid="bib36">Matsumoto et al., 1999</xref>) and associates with the adapter protein Fc receptor gamma chain (FcRγ, encoded by <italic>Fcer1g</italic>) (<xref ref-type="bibr" rid="bib75">Yamasaki et al., 2008</xref>). Signalling by MINCLE requires binding of the kinase SYK to the phosphorylated ITAM of the FcRγ, and proceeds via the CARD9-BCL10-MALT1 complex to activation of NFκB and expression of inflammatory target genes (<xref ref-type="bibr" rid="bib72">Werninghaus et al., 2009</xref>; <xref ref-type="bibr" rid="bib45">Ostrop and Lang, 2017</xref>). In addition to TDM, several additional glycolipids from the mycobacterial cell wall were recently identified as ligands for CLR, most of them like MINCLE members of the FcRγ-coupled DECTIN-2 family (<xref ref-type="bibr" rid="bib29">Ishikawa et al., 2017</xref>). MCL, closely related to MINCLE and able to heterodimerize with it, also can bind TDM and in addition glycero-monomycolate (<xref ref-type="bibr" rid="bib18">Furukawa et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">Miyake et al., 2013</xref>); DECTIN-2 binds mannose-capped LAM (<xref ref-type="bibr" rid="bib76">Yonekawa et al., 2014</xref>) and DCAR is a receptor for mycobacterial phosphatidyl-inositol mannosides (<xref ref-type="bibr" rid="bib66">Toyonaga et al., 2016</xref>). The prototypic myeloid signaling CLR, DECTIN-1 directly recruits SYK through its non-classical ITAM (<xref ref-type="bibr" rid="bib54">Rogers et al., 2005</xref>) it, too, binds and is activated by an yet unidentified mycobacterial ligand (<xref ref-type="bibr" rid="bib55">Rothfuchs et al., 2007</xref>). Since the signals emanating from the interaction of multiple CLR with MTB are transmitted through SYK-CARD9, it is not surprising that CARD9-deficient mice are highly susceptible to infection with MTB and succumb with high bacterial burden in the organs (<xref ref-type="bibr" rid="bib13">Dorhoi et al., 2010</xref>). Knockout mice for individual CLR showed less severe phenotypes but were, dependent on the infection model employed, moderately more susceptible to infection (<xref ref-type="bibr" rid="bib74">Wilson et al., 2015</xref>; <xref ref-type="bibr" rid="bib9">Behler et al., 2015</xref>; <xref ref-type="bibr" rid="bib8">Behler et al., 2012</xref>; <xref ref-type="bibr" rid="bib31">Lee et al., 2012</xref>).</p><p>Already in the first report on MINCLE, the inducible expression in response to TLR stimulation with LPS and by the cytokine TNF was reported (<xref ref-type="bibr" rid="bib36">Matsumoto et al., 1999</xref>). Indeed, TNF is essential for the upregulation of MINCLE in macrophages stimulated with the cord factor and for the Th17 promoting effect of the adjuvant CAF01 that contains the MINCLE ligand TDB (<xref ref-type="bibr" rid="bib59">Schick et al., 2020</xref>). In contrast, the Th2 cytokines IL-4 and IL-13 downregulate expression of MINCLE, MCL, and DECTIN-2, in human monocytes/macrophages and DC, as well as in mouse bone marrow-derived macrophages (<xref ref-type="bibr" rid="bib26">Hupfer et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Ostrop et al., 2015</xref>). This inhibitory effect of the Th2 cytokines IL-4 and IL-13 depends on the transcription factor STAT6 and is associated with a reduced production of G-CSF and TNF by macrophages stimulated with the MINCLE ligand TDB, but not after stimulation with LPS (<xref ref-type="bibr" rid="bib26">Hupfer et al., 2016</xref>). Thus, expression of the DECTIN-2 family CLR MINCLE, MCL, and DECTIN-2 is subject to a substantial regulation by the cytokines TNF and IL-4, which are key factors in type 1 and type 2 immune responses, respectively. Since type 2 immunity is a hallmark of many helminth infections, the question arises whether the expression and function of DECTIN-2 family CLR may be compromised during helminth infection in vivo (<xref ref-type="bibr" rid="bib30">Lang and Schick, 2017</xref>).</p><p>Here, we have investigated the functional impact of IL-4 and helminth infection on myeloid responses to mycobacteria or the cord factor-based adjuvant TDB in vitro and in vivo. Our data show that IL-4 impairs MINCLE expression on monocytes in vivo, but does not interfere with phagocytosis of BCG. Underlying helminth infection attenuated immune responses to recombinant protein together with different adjuvants in the spleen but not in draining lymph nodes. The specific impairment of Th17 responses to MINCLE-dependent adjuvant indicates the contribution of downregulation of DECTIN-2 family CLR to vaccine antagonism induced by helminth infection.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>IL-4 impairs upregulation of MINCLE and other DECTIN-2 family CLR in macrophages stimulated with BCG</title><p>In previous work, we observed that IL-4 and IL-13 downregulate expression of MINCLE, MCL, and DECTIN-2 when macrophages were stimulated with the MINCLE ligand TDB, but not after triggering TLR4 with LPS (<xref ref-type="bibr" rid="bib26">Hupfer et al., 2016</xref>). Since mycobacteria contain multiple ligands for CLR and TLR, we were interested whether IL-4 has any impact on changes in DECTIN-2 family CLR expression in macrophages stimulated with <italic>M. bovis</italic> BCG (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Stimulation of bone marrow-derived macrophages (BMM) with BCG caused the strongest induction of MINCLE (up to 400-fold after 48 hr) and was reduced significantly by IL-4 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). A similar pattern of inducibility and regulation by IL-4 was observed for DECTIN-2 and MCL, albeit the increases at the mRNA level were more moderate (e.g. 50-fold for DECTIN-2 and 8-fold for MCL after stimulation with BCG) (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). IL-4 did not inhibit, but actually increased expression of DECTIN-1 (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), confirming a selective impact on DECTIN-2 family CLR. The inhibitory effect of IL-4 on BCG-induced expression of MINCLE and DECTIN-2 was also evident at the protein level, when analysed by flow cytometry (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>). Regulation of MCL could not be validated at the protein level because no antibody for flow cytometry was available. DECTIN-1 surface protein levels were increased by IL-4 (<xref ref-type="fig" rid="fig1">Figure 1G</xref>) consistent with the quantitative real time PCR (qRT-PCR) data and previously published results (<xref ref-type="bibr" rid="bib73">Willment et al., 2003</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>IL-4 impairs upregulation of MINCLE and other DECTIN-2 family C-type lectin receptor (CLR) in macrophages stimulated with bacille Calmette-Guerin (BCG).</title><p>(<bold>A–D</bold>) C57BL/6 bone marrow-derived macrophages (BMM) were stimulated as indicated in presence or absence of IL-4 for 6, 24, or 48 hr. BCG was used at MOI 10. MINCLE (<bold>A</bold>), DECTIN-2 (<bold>B</bold>), MCL (<bold>C</bold>), and DECTIN-1 (<bold>D</bold>) mRNA expression was determined by quantitative real-time PCR (qRT-PCR) shown as fold change calibrated to unstimulated control. Data are depicted as mean + SD from two independent experiments performed in biological duplicates. (<bold>E–G</bold>) BMM were stimulated with BCG at the indicated MOI in the presence or absence of IL-4 for 24 hr, followed by staining for MINCLE (<bold>E</bold>), DECTIN-2 (<bold>F</bold>), or DECTIN-1 (<bold>G</bold>) expression. Representative stainings are shown as histogram overlay (left panel), for quantification (right panel) the median fluorescence intensity of the isotype control staining was subtracted from the respective CLR signal to obtain the ΔMFI. Each point represents one mouse, pooled from at least two independent experiments. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 in Wilcoxon signed rank test.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data <xref ref-type="fig" rid="fig1">Figure 1</xref> (qRT-PCR and flow cytometry analysis of CLR in macrophages).</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-72923-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-72923-fig1-v1.tif"/></fig></sec><sec id="s2-2"><title>IL-4 does not affect phagocytosis of BCG, but inhibits cytokine production</title><p>Several CLR, including DECTIN-2 and MCL, are phagocytic receptors (<xref ref-type="bibr" rid="bib27">Ifrim et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Graham et al., 2012</xref>). Therefore, we next measured phagocytosis of fluorescent BCG (expressing DsRed) by flow cytometry in the presence or absence of IL-4 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). BMM infected with BCG-DsRed in different MOI dose-dependently ingested the mycobacteria, IL-4 had no impact on phagocytosis after 6 and 24 hr (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We next determined whether phagocytosis of BCG requires MINCLE or FcRγ, the common adapter protein of the CLR MINCLE, DECTIN-2, and MCL. Uptake of fluorescent BCG was comparable to WT cells in <italic>Clec4e<sup>-/-</sup></italic> and <italic>Fcer1g<sup>-/-</sup></italic> BMM (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). In contrast, the high levels of the cytokines G-CSF and TNF in supernatants of BMM infected with BCG were significantly reduced by co-treatment with IL-4 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), extending our previous results for TDB (<xref ref-type="bibr" rid="bib26">Hupfer et al., 2016</xref>) to the response induced by whole mycobacteria. Stimulation of BMM deficient in MINCLE or in the FcRγ chain with BCG led to a reduced production of TNF and G-CSF, confirming the contribution of this receptor to macrophage activation by mycobacteria (<xref ref-type="bibr" rid="bib28">Ishikawa et al., 2009</xref>; <xref ref-type="bibr" rid="bib60">Schoenen et al., 2010</xref>; <xref ref-type="fig" rid="fig2">Figure 2B</xref>). Of interest, the inhibitory effect of IL-4 was still visible in MINCLE-deficient BMM for G-CSF but not for TNF; in addition, it was much less pronounced than in WT BMM (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), indicating that downregulation of MINCLE is a prominent mechanism of IL-4-induced impairment of macrophage cytokine production to mycobacteria. Reduced cytokine production in <italic>Clec4e<sup>-/-</sup></italic> and <italic>Fcer1g<sup>-/-</sup></italic> BMM was not due to a defect in the uptake of BCG (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>IL-4 does not affect phagocytosis of bacille Calmette-Guerin (BCG) but inhibits cytokine production.</title><p>(<bold>A</bold>) C57BL/6 bone marrow-derived macrophages (BMMs) were infected with different MOI of fluorescent BCG-Dsred co-treated with IL-4 or not as indicated. Phagocytic uptake was measured via flow cytometry. (<bold>A</bold>) Representative histograms show phagocytosis of BCG by detection of fluorescent DsRed signal in BMMs. Quantitative analysis of phagocytosis based on percentage of BCG-positive cells at 6 and 24 hr post infection. Data is depicted from two to three independent experiments performed in biological duplicates. (<bold>B</bold>) C57BL/6 (<italic>WT</italic>), MINCLE knockout (<italic>Clec4e<sup>-/-</sup></italic>), and FcRγ (<italic>Fcer1g<sup>-/-</sup></italic>) BMM were stimulated with BCG for 24 hr. Production of G-CSF and TNF was measured from cell culture supernatants via ELISA. No significant cytokine production was detected from non-stimulated BMM. Data is depicted from three independent experiments performed in biological duplicates. (<bold>C</bold>) Phagocytosis of fluorescent BCG is unaltered in BMM deficient in MINCLE (<italic>Clec4e<sup>-/-</sup></italic>) or FcRγ (<italic>Fcer1g<sup>-/-</sup></italic>). Mean percentages of one representative experiment out of two (<italic>Fcer1g<sup>-/-</sup></italic>) and three (<italic>Clec4e<sup>-/-</sup></italic>) performed. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data <xref ref-type="fig" rid="fig2">Figure 2</xref> (phagocytosis and cytokine production).</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-72923-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-72923-fig2-v1.tif"/></fig></sec><sec id="s2-3"><title>Overexpression of IL-4 inhibits MINCLE expression after intraperitoneal infection with BCG</title><p>Given the impact of IL-4 on BCG-induced MINCLE expression in vitro, we next used intraperitoneal infection of mice with BCG for analysis of MINCLE regulation by IL-4 in vivo. Hydrodynamic injection of minicircle DNA encoding IL-4 was used to overexpress IL-4 from hepatocytes in vivo (<xref ref-type="bibr" rid="bib64">Suda and Liu, 2007</xref>). Serum levels of IL-4 after injection of 0.25 and 0.5 µg IL-4-encoding minicircle DNA ranged between 1 and 2 ng/ml, whereas IL-4 was not detectable in control mice (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Peritoneal lavage cells were obtained 24 hr after i.p. infection with 4×10<sup>7</sup> CFU BCG and MINCLE expression on Ly6C<sup>hi</sup> monocytes and Ly6G<sup>+</sup> neutrophils was analysed by flow cytometry (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, gating strategy). Compared to the PBS control mice, MINCLE cell surface expression increased after BCG infection in monocytes and in neutrophils, which was abrogated by IL-4 overexpression specifically in monocytes but not neutrophils (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Overexpression of IL-4 or co-infection with <italic>Nippostrongylus</italic> <italic>brasiliensis</italic> impair MINCLE upregulation on peritoneal monocytes but does not reduce phagocytosis upon bacille Calmette-Guerin (BCG) infection.</title><p>(<bold>A</bold>) IL-4 concentration in serum of mice injected with IL-4 minicircle. C57BL/6 mice were hydrodynamically injected with 0.25 or 0.5 µg of IL-4 plasmid (i.v.) or Ringer solution. Five days (0.5 µg) or 7 days later (0.25 µg) mice were sacrificed and serum IL-4 levels were determined via ELISA (n=5–6 mice per group). n.d.=not detectable. (<bold>B, C</bold>) 0.25 µg of IL-4 plasmid or Ringer solution was hydrodynamically injected into C57BL/6 wildtype mice. Two days later mice were infected i.p. with 40×10<sup>6</sup> CFU of <italic>Mycobacterium bovis</italic> BCG. (<bold>B</bold>) Generic gating strategy for flow cytometry data. Monocytes were characterized as lineage<sup>-</sup>CD11b<sup>+</sup>SiglecF<sup>-</sup>Ly6C<sup>+</sup> cells. Neutrophils were characterized as lineage<sup>-</sup>CD11b<sup>+</sup>SiglecF<sup>-</sup>Ly6G<sup>+</sup> cells. Lineage marker: CD3, CD19, NK1.1. (<bold>C</bold>) Histograms depict MINCLE surface expression on Ly6C<sup>hi</sup> monocytes and neutrophils 24 hr p.i. analysed via flow cytometry. Quantitative analysis of MINCLE surface expression shown as median fluorescence intensity (MFI). Fluorescence minus one control (FMO) was substracted. Infected <italic>MINCLE-/-</italic> mice were used as staining controls to exclude unspecific binding of 4A9 antibody. Data is depicted from two independent experiments (2–7 mice per group in total, each dot corresponding to one mouse). **p0.01; ns = not significant. (<bold>D–E</bold>) C57BL/6 mice were s.c. infected with <italic>N. brasiliensis</italic> or left uninfected followed by <italic>M. bovis</italic> BCG-Dsred infection (40×10<sup>6</sup> CFU/mouse) on day 10 p.i. Twenty-four hr later mice were sacrificed. (<bold>D</bold>) Representative histograms of eosinophil population of BCG-infected and <italic>N. brasiliensis</italic> co-infected mouse. Bar graphs show relative percentage of myeloid cell populations as indicated. (<bold>E</bold>) MINCLE surface expression was analysed on peritoneal Ly6C<sup>hi</sup> monocytes and neutrophils via flow cytometry. Quantitative analysis of MINCLE surface expression shown as MFI normalized to BCG-infected mice. FMO was substracted. Data is depicted from three independent experiments (11–13 mice per group in total). *p&lt;0.05, ** p&lt;0.01, ***p&lt;0.001. (<bold>F</bold>) C57BL/6 mice were s.c. infected with <italic>N. brasiliensis</italic> followed by <italic>M. bovis</italic> BCG-Dsred infection (40×10<sup>6</sup> CFU/mouse) or non-fluorescent BCG (nf) on day 10 p.i. Twenty-four hr after BCG infection, phagocytosis was measured by detection of PE signal in monocytes or neutrophils. Quantitative analysis of the percentage of BCG-positive monocytes.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data <xref ref-type="fig" rid="fig3">Figure 3</xref> (cytokine and flow cytometry data).</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-72923-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-72923-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title>Co-infection with <italic>N. brasiliensis</italic> impairs MINCLE upregulation on peritoneal monocytes, but does not reduce phagocytosis, upon BCG infection</title><p>Infection with the hookworm <italic>N. brasiliensis</italic> induces a strong Th2 response characterized by high levels of IL-4. We therefore asked whether pre-existing infection with <italic>N. brasiliensis</italic> interferes with MINCLE expression on myeloid cells during mycobacterial infection. The peritoneal cavity of <italic>N. brasiliensis</italic>-infected mice contained a much higher proportion of SiglecF<sup>+</sup> eosinophils (nearly 40% compared to 10% in controls), whereas the fraction of Ly6C<sup>hi</sup> monocytes was reduced (from 30% to 20%), and the low percentage of resident monocytes/macrophages was not altered by helminth infection (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Eosinophils were negative for MINCLE surface staining. MINCLE staining on inflammatory monocytes from BCG-infected mice was significantly reduced when co-infected with <italic>N. brasiliensis</italic> compared to control mice infected only with BCG (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). In contrast, the cell surface expression of MINCLE on neutrophils was not altered by underlying <italic>N. brasiliensis</italic> infection (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). The use of fluorescent BCG-DsRed enabled us to determine the cell types and percentages of peritoneal cells that had ingested mycobacteria 24 hr after injection (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). While on average 12% of Ly6C<sup>hi</sup> monocytes contained BCG-DsRed, no specific signal was measurable for the peritoneal neutrophils. Co-infection with <italic>N. brasiliensis</italic> did not change the phagocytosis of BCG by inflammatory monocytes in the peritoneal cavity (<xref ref-type="fig" rid="fig3">Figure 3F</xref>).</p></sec><sec id="s2-5"><title>Co-infection with <italic>N. brasiliensis</italic> or with <italic>S. mansoni</italic> suppresses Th1/Th17 induction by a MINCLE-dependent adjuvant in the spleen</title><p>Downregulation of MINCLE expression on monocytes of mice with <italic>N. brasiliensis</italic> infection led us to ask whether vaccination responses to protein antigen induced by a MINCLE-dependent adjuvant would be inhibited by helminth infections. We investigated this question in chronic (non-transient) <italic>S. mansoni</italic> and acute (transient) <italic>N. brasiliensis</italic> infection models. Infected and control mice were immunized with the recombinant fusion protein H1, comprising the MTB antigens Ag85B and ESAT-6, adsorbed to the adjuvant CAF01 (a combination of the MINCLE ligand TDB incorporated into cationic liposomes) (<xref ref-type="bibr" rid="bib2">Agger et al., 2008</xref>). We and others previously showed that subcutaneous injection of the CAF01 adjuvant with H1 induces robust antigen-specific production of IFNγ and IL-17 by CD4+ T cells (<xref ref-type="bibr" rid="bib12">Desel et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Lindenstrøm et al., 2009</xref>; <xref ref-type="bibr" rid="bib33">Lindenstrøm et al., 2012</xref>). Similar results were obtained for the combination of CAF01 with the chlamydial antigen CTH522 (<xref ref-type="bibr" rid="bib42">Nguyen et al., 2020</xref>).</p><p><italic>S. mansoni</italic> causes a chronic infection in mice, with fertile, adult worms residing in the portal vein system. Trapping of eggs in tissues (especially the liver) is a strong stimulus for Th2-type immunity, which dominates in the later phase of infection after 8–9 weeks. We therefore immunized mice infected with <italic>S. mansoni</italic> in this chronic phase subcutaneously with H1/CAF01 in the flank of the mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We first analysed whether schistosomal infection indeed enhanced IL-4 production by T cells (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). While only very low levels of IL-4 were detectable in the supernatants of draining lymph node cells, splenocytes of <italic>S. mansoni</italic>-infected mice produced significant amounts of IL-4 when T cells were polyclonally stimulated with anti-CD3 in vitro. Thus, <italic>S. mansoni</italic> infection generated a Th2 milieu in the spleen, but not in the inguinal lymph node. Induction of antigen-specific Th1 and Th17 cells, detected by robust secretion of IFNγ and IL-17, respectively, was observed after immunization in both lymph nodes and spleen (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). Infection with <italic>S. mansoni</italic> had no impact on H1-specific or anti-CD3-induced production of IFNγ, IL-17, and of IL-10 from draining inguinal lymph nodes (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In contrast, the antigen-specific splenocyte responses to H1 were strongly reduced in the case of IFNγ, IL-17, and also for IL-10 (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). <italic>S. mansoni</italic> infection also suppressed IFNγ, but not IL-17 production triggered by polyclonal anti-CD3 stimulation, whereas secretion of IL-10 was much higher from splenocytes of <italic>S. mansoni</italic>-infected mice (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Together, these data show that <italic>S. mansoni</italic> infection establishes a Th2 environment in the spleen but not in the inguinal lymph nodes, which corresponds to suppression of Th1 and Th17 responses after CAF01-adjuvanted immunization in splenocytes but has no impact on draining lymph node cells.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Co-infection with <italic>Schistosoma mansoni (S.m.</italic><italic>)</italic> suppresses Th1/Th17 induction by a MINCLE-dependent adjuvant in the spleen but not in the draining lymph node.</title><p>(<bold>A</bold>) Scheme of experimental procedure. <italic>Cercariae</italic> of <italic>S.m</italic>. were injected s.c. into C57BL/6 mice. Eight to 9 weeks p.i. mice were immunized with CAF01 (<bold>B, C, D</bold>) or CpG ODN (<bold>E, F</bold>). Seven days after immunization, mice were sacrificed and inguinal lymph node cells and spleen cells were re-stimulated with H1 in vitro. Draining inguinal lymph node cells or splenocytes were re-stimulated with H1 or anti-CD3 for 96 hr. IL-17, IFNγ, IL-10, and IL-4 production was measured from cell culture supernatants by ELISA. Data is shown from three independent experiments (n=18 mice per group in total) for IFNγ, IL-17, and IL-10 (<bold>C, D</bold>) and from two independent experiments (n=13 mice) for IL-4 (<bold>B</bold>). (<bold>E, F</bold>) Data is shown from one experiment (n=5 mice per group in total). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. Dashed horizontal lines indicate the limit of detection for each cytokine.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data <xref ref-type="fig" rid="fig4">Figure 4</xref> (cytokine results).</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-72923-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-72923-fig4-v1.tif"/></fig><p>To determine whether <italic>S. mansoni</italic>-induced inhibition of antigen-specific immune responses by splenocytes, but not draining lymph node cells, was specific for the MINCLE-dependent adjuvant CAF01, we immunized mice with H1 together with the TLR9 ligand CpG ODN 1826 as adjuvant. Using the same protocol as before for H1/CAF01, we observed, as demonstrated previously (<xref ref-type="bibr" rid="bib72">Werninghaus et al., 2009</xref>), strong induction of IFNγ-producing T cells but a lack of IL-17 production upon re-stimulation of draining lymph node cells or splenocytes (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). Thus, it was not possible to compare inhibition of Th17 responses by helminth infection between adjuvants. However, <italic>S. mansoni</italic> did not generally downregulate IL-17 production from T cells, as the levels after anti-CD3 stimulation were unaffected (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). Similar to the impact on immunization with CAF01, <italic>S. mansoni</italic> infection strongly reduced antigen-specific and non-specific IFNγ secretion by splenocytes but not by draining lymph node cells (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). Thus, <italic>S. mansoni</italic> infection caused a general suppression of the splenic Th1 response to immunization, regardless whether the MINCLE-dependent adjuvant CAF01 was used or the TLR9-dependent CpG ODN 1826.</p><p>To address the effect of transient helminth infection, mice were injected subcutaneously with L3 larvae of <italic>N. brasiliensis</italic> and were immunized 5 days later with H1/CAF01 in the footpads of both hindlegs (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). The local tissue swelling to subcutaneous vaccination in the footpad was not changed in mice with underlying <italic>N. brasiliensis</italic> infection (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). The total number of cells in the draining inguinal lymph nodes 7 days after immunization was strongly increased compared to non-vaccinated mice, but significantly reduced in mice infected with <italic>N. brasiliensis</italic>; in contrast, the number of splenocytes was unaltered by helminth infection (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). As was already observed after infection with <italic>S. mansoni</italic>, establishment of IL-4-producing Th2 T cells was only detected in spleens of <italic>N. brasiliensis</italic>-infected mice but not in their popliteal and inguinal lymph nodes (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Upon re-stimulation of lymph node cells with H1 in vitro, the antigen-specific production of IFNγ, IL-17, or IL-10 was not affected by <italic>N. brasiliensis</italic> co-infection (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). In striking contrast, splenocytes from co-infected mice generated significantly less IFNγ and IL-17, but not IL-10, when re-stimulated with H1 antigen, whereas for polyclonal stimulation with anti-CD3 antibody only a reduction for IFNγ was observed (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). When mice were immunized with H1 together with the TLR4-dependent adjuvant G3D6A, IFNγ production by splenocytes was diminished in mice infected with <italic>N. brasiliensis,</italic> whereas antigen-specific secretion of IL-17, IL-10, and IL-4 were not changed (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). However, polyclonal stimulation of T cells from the spleens of <italic>N. brasiliensis</italic>-infected mice caused secretion of significant IL-4 (<xref ref-type="fig" rid="fig5">Figure 5G</xref>), as after immunization with the MINCLE-dependent adjuvant CAF01 (<xref ref-type="fig" rid="fig5">Figure 5D</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Co-infection with <italic>Nippostrongylus</italic> <italic>brasiliensis</italic> suppresses Th1/Th17 induction by a MINCLE-dependent adjuvant in the spleen but not in the draining lymph node.</title><p>(<bold>A</bold>) Scheme of experimental procedure. C57BL/6 mice were infected subcutaneously in the flank with 500 L3 <italic>larvae</italic> of <italic>N. brasiliensis</italic> in 200 µl PBS. Five days p.i. mice were immunized with H1/CAF01 (<bold>B–F</bold>) or H1/G3D6A (<bold>G</bold>). Seven days after immunization, mice were sacrificed, and inguinal and popliteal lymph node cells and spleen cells were re-stimulated with H1 in vitro. (<bold>B</bold>) Footpad swelling was measured over a period of 1 week after immunization with H1/CAF01 until mice were sacrificed (day 7 after immunization). The increase in footpad swelling is shown as mean + SD for the indicated time points (n=10–11 mice for each data point). (<bold>C</bold>) Absolute cell number of draining inguinal and popliteal lymph node cells (LN) and spleen on day 7 after H1/CAF01. (<bold>D–G</bold>) Draining inguinal and popliteal lymph node cells or splenocytes were re-stimulated with H1, anti-CD3, or left untreated (mock) for 96 hr, followed by cytokine determination by ELISA. (<bold>D</bold>) IL-4 levels produced by draining lymph node cells (left) or splenocytes (right). (<bold>E, F</bold>) IL-17, IFNγ, and IL-10 cytokine production by draining lymph node cells (<bold>E</bold>) and splenocytes (<bold>F</bold>). (<bold>G</bold>) Immunization of C57BL/6 mice with H1 in G3D6A adjuvant. Seven days after immunization mice were sacrificed and splenocytes were treated as described in (<bold>D, E</bold>). All data is shown from two (<bold>B–F</bold>) or three (<bold>G</bold>) independent experiments (n=9–14 mice per group in total). p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. Dashed horizontal lines indicate the limit of detection for each cytokine.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Soruce data <xref ref-type="fig" rid="fig5">Figure 5</xref> (cytokine results).</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-72923-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-72923-fig5-v1.tif"/></fig><p>Together, these results indicate that underlying <italic>N. brasiliensis</italic> infection attenuated cell expansion in the draining lymph node, yet the differentiation toward Th1/Th17 at this site was not affected. In contrast, hookworm infection did interfere with antigen-specific IFNγ and IL-17 production by splenic T cells, correlating with strongly enhanced production of IL-4 by splenocytes (but not draining lymph node cells). The inhibitory effect of infection on IFNγ appears to be general, antigen- and adjuvant-non-specific, because it was also observed after polyclonal T cell stimulation and independent of the pattern recognition receptor pathway triggered by the adjuvant used. In contrast, the impairment of Th17 induction in the spleen by <italic>N. brasiliensis</italic> was specific for the MINCLE-dependent CAF01. Taken together, immunization experiments in two helminth infection models demonstrated organ-specific inhibition of Th responses in the spleen, with antigen-specific inhibition of CAF01-induced, MINCLE-dependent IL-17 production.</p><p>Finally, we employed mice deficient in IL-4 and IL-13 (designated here as 4-13ko) to determine whether the thwarted MINCLE-dependent Th1/Th17 cytokine responses in helminth-infected mice are caused by the action of these Th2 cytokines. Indeed, in immunization experiments in mice infected with <italic>N. brasiliensis,</italic> we found that the reduced induction of antigen-specific and anti-CD3-triggered production of IFNγ was partially recovered in 4-13ko (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). The production of IL-17 by splenocytes in response to re-stimulation with H1 was not only significantly higher in <italic>N. brasiliensis</italic>-infected 4-13ko than in infected C57BL/6, but in fact exceeded the levels found in non-infected C57BL/6 mice (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). In contrast, IL-10 production was lower in infected 4-13ko compared to C57BL/6 mice (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) and no IL-4 was found as expected in the supernatants of 4-13ko splenocytes (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Thus, the increased production of IL-4 and/or IL-13 in the spleens of mice infected with <italic>N. brasiliensis</italic> is responsible for the low levels of antigen-specific Th1/Th17 induction by the MINCLE-dependent adjuvant CAF01.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Inhibition of Th1/Th17 induction in <italic>Nippostrongylus brasiliensis</italic> infection depends on IL-4 or IL-13.</title><p>C57BL/6 or of <italic>Il4<sup>-/-</sup>Il13<sup>-/-</sup></italic> mice were infected with <italic>N. brasiliensis</italic> or not as indicated and immunized s.c. with H1/CAF01 5 days later. On day 7 after immunization, mice were sacrificed and splenocytes were re-stimulated with H1 or anti-CD3 for 96 hr. Cytokines were measured by ELISA. (<bold>A</bold>) IFNγ, (<bold>B</bold>) IL-17, (<bold>C</bold>) IL-10, (<bold>D</bold>) IL-4. Data shown is pooled from four independent experiments (n=15–17 mice per group in total). p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. Dashed horizontal lines indicate the limit of detection for each cytokine.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Soruce data <xref ref-type="fig" rid="fig6">Figure 6</xref> (cytokine results).</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-72923-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-72923-fig6-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we show for the first time that IL-4 impairs MINCLE expression and function in vivo. Two different models of helminth infection revealed an organ-specific impairment of Th17 induction by the MINCLE-dependent adjuvant CAF01 in the spleen. These findings establish an in vivo impact of IL-4 on the expression and function of MINCLE that may have important consequences for the detection of and the response to mycobacteria and their cell wall glycolipids in infection or vaccination.</p><p>In previous work, we have found that IL-4 downregulates expression of DECTIN-2 family CLRs in murine and human macrophages and DC (<xref ref-type="bibr" rid="bib26">Hupfer et al., 2016</xref>). Here, we first extended these findings by showing that upregulation of these CLR by BCG was also impaired by IL-4 in BMM. Importantly, using overexpression of IL-4 in vivo by hydrodynamic injection of minicircle DNA, the upregulation of MINCLE on monocytes recruited after BCG infection to the peritoneum was strongly inhibited. This effect was cell type-specific, as it was not observed on recruited neutrophils, and it was also caused by infection with <italic>N. brasiliensis</italic>. We have previously shown that the downregulation of MINCLE in mouse macrophages by IL-4 requires the transcription factor STAT6 (<xref ref-type="bibr" rid="bib26">Hupfer et al., 2016</xref>). It is at present unknown which other signalling pathways downstream or in parallel to STAT6 are involved in this process and how they may differ in monocytes/macrophages vs. neutrophils.</p><p>IL-4 and <italic>N. brasiliensis</italic> infection did not interfere with phagocytosis of BCG in vitro or in vivo, showing that high-level expression of DECTIN-2 family CLR is not required for phagocytosis of mycobacteria. This may seem surprising, as DECTIN-2 and MCL are phagocytic receptors (<xref ref-type="bibr" rid="bib58">Sato et al., 2006</xref>; <xref ref-type="bibr" rid="bib3">Arce et al., 2004</xref>), and mycobacteria strongly express ligands for both receptors (mannans and TDM). A lack of DECTIN-2 family CLR appears to be compensated by the large number of other receptors contributing to phagocytosis of mycobacteria, including the mannose receptor CD206, integrins like CD11b, or the inhibitory CLR DC-SIGN (<xref ref-type="bibr" rid="bib51">Rajaram et al., 2017</xref>; <xref ref-type="bibr" rid="bib20">Geijtenbeek et al., 2003</xref>; <xref ref-type="bibr" rid="bib38">Melo et al., 2000</xref>).</p><p>Importantly, IL-4-treated macrophages not only downregulated DECTIN-2 family CLR, but in addition produced significantly less cytokines after stimulation with BCG. A similar reduction in G-CSF and TNF production was observed here in MINCLE- and FcRγ-deficient BMM. These observations suggests that IL-4 produced during helminth infection could interfere with the initial sensing of invading mycobacteria by pulmonary macrophages and thereby mute the generation of an inflammatory chemokine/cytokine as well as an anti-microbial response. If so, impaired detection of inhaled MTB by alveolar and lung macrophages may favour intracellular mycobacterial survival and replication, providing a mechanism underlying the reported increase in tuberculin skin test conversion reported for helminth-infected household contacts of patients with smear-positive tuberculosis (<xref ref-type="bibr" rid="bib69">Verhagen et al., 2012</xref>). Whether IL-4 impairs functional macrophage responses to mycobacteria primarily through downregulation of MINCLE and DECTIN-2 family CLRs or by inhibiting other cytokine-inducing pathways is an open question that needs to be investigated in future work.</p><p>In addition to the response of macrophages to BCG, we investigated how type 2 immune bias during helminth infections impacts on the Th cell differentiation after recombinant subunit vaccination with MINCLE-dependent and -independent adjuvants. Induction of Th17 immunity triggered by the MINCLE-dependent adjuvant CAF01 was suppressed in two models of helminth infection in the spleen, but not in the draining popliteal and inguinal lymph nodes. This organ-specific impact of infection with <italic>N. brasiliensis</italic> and <italic>S. mansoni</italic> on splenic Th cell differentiation was associated with a stronger Th2 bias in the spleen, as demonstrated by the robustly increased levels of IL-4 and IL-10 released by splenocytes, but not draining lymph node cells, from worm-infected mice after polyclonal stimulation with anti-CD3 (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>). Compartmentalized overexpression of IL-10 in the spleens but not lymph nodes has been described before in mice with chronic schistosomiasis (<xref ref-type="bibr" rid="bib68">van der Vlugt et al., 2012</xref>). Our data suggest that such a restriction of Th2 bias to the spleen also applies to IL-4-producing T cells in both helminth infections. For infection with <italic>N. brasiliensis</italic>, we tested mice doubly deficient in <italic>Il4</italic> and <italic>Il13</italic> and confirmed a causal role of IL-4 and/or IL-13 in inhibition of both Th1 and Th17 differentiation in vivo after MINCLE-dependent immunization (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Similar to the effect of IL-4 on macrophage cytokine responses, it remains to be dissected for the Th1/Th17 adjuvant effect whether the inhibitory effect of IL-4/IL-13 signals is partially or primarily caused by downregulation of DECTIN-2 family CLR in vivo.</p><p>Helminth infection did not alter the production of IL-17, IFNγ, or IL-10 by antigen-specific CD4+ T cells in the draining lymph nodes, as determined by re-stimulation of a defined number of cells with recombinant H1. However, the cellularity of the lymph nodes was significantly diminished by <italic>N. brasiliensis</italic>, suggesting that the total number of antigen-specific Th1/Th17 cells in the draining lymph nodes is reduced by co-existent worm infection. Decreased peripheral lymph node size and cellularity has been reported in mice infected with the enteric helminth <italic>H. polygyrus</italic> and was associated with a dampened immune response to infection with BCG, affecting primarily B and T lymphocytes (<xref ref-type="bibr" rid="bib17">Feng et al., 2018</xref>). In the <italic>H. polygyrus</italic> model, the gut-draining mesenteric lymph nodes were increased in size, suggesting that atrophy of peripheral lymph nodes was due to a redistribution of lymphocytes (<xref ref-type="bibr" rid="bib17">Feng et al., 2018</xref>). Furthermore, in mice infected with <italic>Helicobacter pylori</italic>, we have recently shown that concomitant schistosome infection lead to a redistribution of bacterial-specific CXCR3+ T cells resulting in reduced bacterial growth control (<xref ref-type="bibr" rid="bib10">Bhattacharjee et al., 2019</xref>). Cell numbers and size of lymph nodes are controlled by entry of lymphocytes via the high endothelial venules and exit through the efferent lymphatics.</p><p>While the inhibition of IFNγ production by splenocytes from helminth-infected mice was impaired also after immunization with the TLR4 ligand G3D6A and the TLR9 ligand CpG ODN as adjuvants, IL-17 production was specifically impaired when the MINCLE-dependent CAF01 was the adjuvant. In addition, antigen-non-specific production of IFNγ by polyclonal anti-CD3 stimulation was also inhibited in splenocytes from helminth-infected mice, suggesting a general inhibitory effect of <italic>N. brasiliensis</italic> and <italic>S. mansoni</italic> infection that was not observed for production of IL-17. Thus, underlying helminth infection affects the CAF01-induced antigen-specific Th cell response in the spleen in a manner that could be explained by downregulation of MINCLE expression. Whether this is indeed the case needs to be further investigated in future studies comparing myeloid cells in spleen, peripheral lymph node, and subcutaneous injection site tissue. Detection and quantification of MINCLE surface protein on myeloid cells from tissues by flow cytometry is unfortunately complicated by the fact that proteolytic agents commonly used for enzymatic tissue dissociation cause a near-complete loss of specific staining (<xref ref-type="bibr" rid="bib63">Stappers et al., 2021</xref>). For this reason, we employed here the intraperitoneal BCG infection model for assessment of IL-4/helminth effects on myeloid cells in vivo, because it allowed the direct flow cytometric staining of peritoneal exudate cells without the need for enzymatic tissue digestion.</p><p>Interestingly, application of schistosome eggs, a strong inducer of IL-4 and IL-13 production in vivo, prior to infection of mice with <italic>Salmonella typhimurium</italic> downregulated the Th17 response in the gut mucosa and impaired the clearance of the bacteria from the gut (<xref ref-type="bibr" rid="bib61">Schramm et al., 2018</xref>). As the <italic>Salmonella</italic> cell wall contains trehalose phospholipids that bind to and activate MINCLE (<xref ref-type="bibr" rid="bib52">Reinink et al., 2019</xref>), it is possible that induction of IL-17-producing cells during infection requires MINCLE and may be inhibited by schistosome eggs through IL-4/IL-13-induced downregulation of the receptor. Alternatively, IL-4 and IL-10 present in the spleen during helminth infection may act directly on antigen-specific Th cell differentiation after immunization and block Th17 (<xref ref-type="bibr" rid="bib48">Park et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Harrington et al., 2005</xref>) and Th1 bias (<xref ref-type="bibr" rid="bib47">Paludan, 1998</xref>). Employment of conditional knockout mice with cell type-selective deficiency of the IL-4 receptor in myeloid or T cells in future experiments should be helpful to discriminate between these possibilities in our system of immunization in mice with concurrent helminth infection.</p><p>More generally, downregulation of other PRR in addition to DECTIN-2 family CLR during acute or chronic helminth infection may also have a negative impact on vaccines comprising specific PAMPs as adjuvants. Indeed, several papers have demonstrated a diminished baseline expression of TLR2 and TLR9 patients with filarial infection (<xref ref-type="bibr" rid="bib5">Babu et al., 2009a</xref>; <xref ref-type="bibr" rid="bib4">Babu et al., 2005</xref>). Underlying infection with hookworm or filaria were found to downregulate Th1 and Th17 responses in individuals with latent tuberculosis (<xref ref-type="bibr" rid="bib6">Babu et al., 2009b</xref>; <xref ref-type="bibr" rid="bib22">George et al., 2013</xref>). Certainly, helminth-induced immune regulation can interfere by diverse and manifold mechanisms with Th1/Th17 adaptive immunity. It will be worthwhile to investigate further, in animal models and in human patients with helminth infection, whether impaired DECTIN-2 family CLR expression is a significant contributor to thwarting of these protective anti-mycobacterial T cell responses.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain <break/>background <break/>(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6 mice</td><td align="left" valign="bottom">Charles River or Preclinical Experimental <break/>Animal Center <break/>University Hospital Erlangen</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain <break/>background <break/>(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">MINCLE knockout mice</td><td align="left" valign="bottom">Consortium for Functional Glycomics</td><td align="left" valign="bottom"><italic>Clec4e<sup>-/-</sup></italic></td><td align="left" valign="bottom">Wells C et al. 2007J <break/>Immunol PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18490740/">18490740</ext-link></td></tr><tr><td align="left" valign="bottom">Strain, strain <break/>background <break/>(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">FcRγ knockout mice</td><td align="left" valign="bottom">Prof. Dr Falk Nimmerjahn, Erlangen, Germany</td><td align="left" valign="bottom"><italic>Fcer1g<sup>-/-</sup></italic></td><td align="left" valign="bottom">Takai T et al. 1994Cell PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8313472/">8313472</ext-link></td></tr><tr><td align="left" valign="bottom">Strain, strain <break/>background <break/>(<italic>Mus musculus</italic>)</td><td align="char" char="hyphen" valign="bottom">4-13ko mice</td><td align="left" valign="bottom">Prof. AN McKenzie, <break/>Cambridge, UK</td><td align="left" valign="bottom"><italic>Il4<sup>-/-</sup> Il13<sup>-/-</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib37">McKenzie et al., 1999</xref> J Exp Med PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10330435/">10330435</ext-link></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-<break/>mouse Mincle (# 4A9)<break/>Unlabeled</td><td align="left" valign="bottom">MBL</td><td align="left" valign="bottom">MBL-D292-3</td><td align="char" char="." valign="bottom">1:200 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal IgG1 <break/>Isotype unlabeled</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">17-4812-82</td><td align="char" char="." valign="bottom">1:200 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-<break/>mouse CD3-APC-eF780</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">47-0031-82</td><td align="char" char="." valign="bottom">1:100 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-<break/>mouse CD19-APC-eF780</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">47-0193-82</td><td align="char" char="." valign="bottom">1:100 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-<break/>mouse NK1.1-APC-eF780</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">47-5941-82</td><td align="char" char="." valign="bottom">1:100 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-<break/>mouse CD11b-FITC</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">101206</td><td align="char" char="." valign="bottom">1:100 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-<break/>mouse SiglecF-BV421</td><td align="left" valign="bottom">BD</td><td align="char" char="." valign="bottom">562681</td><td align="char" char="." valign="bottom">1:400 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-<break/>mouse Ly6C-PerCP-Cy5.5</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">128012</td><td align="char" char="." valign="bottom">1:200 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-<break/>mouse Ly6G-PE-Cy7</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">127618</td><td align="char" char="." valign="bottom">1:400 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Human monoclonal <break/>anti-mouse Dectin1-APC</td><td align="left" valign="bottom">Miltenyi</td><td align="char" char="hyphen" valign="bottom">130-102-250</td><td align="char" char="." valign="bottom">1:50 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Human monoclonal <break/>anti-mouse Dectin2-APC</td><td align="left" valign="bottom">Miltenyi</td><td align="char" char="hyphen" valign="bottom">130-116-911</td><td align="char" char="." valign="bottom">1:50 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Human IgG1 APC <break/>(Isotype for Dectin2, <break/>Dectin1)</td><td align="left" valign="bottom">Miltenyi</td><td align="char" char="hyphen" valign="bottom">130-113-446</td><td align="char" char="." valign="bottom">1:50 dilution</td></tr><tr><td align="left" valign="bottom">Chemical <break/>compound, drug</td><td align="left" valign="bottom">Mouse Fixable <break/>viability dye eF506</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">65-0866-18</td><td align="char" char="." valign="bottom">1:1000 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat IgG1 APC</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">17-4301-81</td><td align="char" char="." valign="bottom">1:200 dilution</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat IgG1 APC Iso k</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">14-4301-82</td><td align="char" char="." valign="bottom">1:200 dilution</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Mincle Primer<break/>(qRT-PCR)</td><td align="left" valign="bottom">Metabion</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For: gctcacctggtggttatcg<break/>Rev: aggttttgtgcgaaaaagga</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Mcl Primer (qRT-PCR)</td><td align="left" valign="bottom">Metabion</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For: agtaacgtgcatccgagagg<break/>Rev: taacaggacagcaggtccaa</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Dectin2 Primer<break/>(qRT-PCR)</td><td align="left" valign="bottom">Metabion</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For: cagtgaagggactatggtgtca<break/>Rev: ggagccaaatgacttccagt</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Dectin1 Primer<break/>(qRT-PCR)</td><td align="left" valign="bottom">Metabion</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For: atggttctgggaggatggat<break/>Rev: atggttctgggaggatggat</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Hprt Primer<break/>(qRT-PCR)</td><td align="left" valign="bottom">Metabion</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For: tcctcctcagaccgctttt<break/>Rev: cctggttcatcatcgctaatc</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Mincle Probe</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Roche Universal Probe Library (UPL)</td><td align="left" valign="bottom">#15</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Mcl Probe</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Roche UPL</td><td align="left" valign="bottom">#1</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Dectin2 Probe</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Roche UPL</td><td align="left" valign="bottom">#89</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Dectin1 Probe</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Roche UPL</td><td align="left" valign="bottom">#60</td></tr><tr><td align="left" valign="bottom">Sequence-<break/>based reagent</td><td align="left" valign="bottom">Hprt Probe</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Roche UPL</td><td align="left" valign="bottom">#95</td></tr><tr><td align="left" valign="bottom">Recombinant <break/>DNA reagent</td><td align="left" valign="bottom">Minicircle DNA encoding IL-4</td><td align="left" valign="bottom">Dr Stefan Wirtz, Erlangen, Germany</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain <break/>background <break/>(bacteria)</td><td align="left" valign="bottom"><italic>Mycobacterium bovis</italic> <break/>BCG DsRed Danish</td><td align="left" valign="bottom">Dr Anca Dorhoi, Friedrich Löffler Institute, Greifswald, Germany</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain <break/>background <break/>(helminth)</td><td align="left" valign="bottom"><italic>Nippostrongylus brasiliensis</italic></td><td align="left" valign="bottom">Dr David Vöhringer, Erlangen, Germany</td><td align="left" valign="bottom"/><td align="left" valign="bottom">500 L3 larvae per mouse s.c.</td></tr><tr><td align="left" valign="bottom">Strain, strain <break/>background <break/>(helminth)</td><td align="left" valign="bottom"><italic>Schistosoma mansoni</italic></td><td align="left" valign="bottom">Dr Clarissa Prazeres da Costa, Munich, Germany</td><td align="left" valign="bottom">NMRI strain</td><td align="left" valign="bottom">100 cercariae per mouse s.c.</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">CpG ODN1826</td><td align="left" valign="bottom">TIB MOLBIOL</td><td align="char" char="." valign="bottom">180000237</td><td align="left" valign="bottom">0.5 μM (in vitro); 10 nmol <break/>per mouse in vivo</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">CAF01 (TDB+DDA <break/>liposomes)</td><td align="left" valign="bottom">Dr Dennis Christensen, Statens Serum Institute, Copenhagen, Denmark</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Adjuvant, 50 µl injected <break/>s.c. together with H1 protein</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">G3D6A liposomal <break/>formulation</td><td align="left" valign="bottom">Dr<break/>Christian Alexander, <break/>Research Center<break/>Borstel</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Adjuvant, 50 µl injected <break/>s.c. together with H1 protein</td></tr><tr><td align="left" valign="bottom">Peptide, <break/>Recombinant <break/>protein</td><td align="left" valign="bottom">H1 Mycobacterial <break/>antigen</td><td align="left" valign="bottom">Dr Dennis Christensen, Statens Serum Institute, Copenhagen, Denmark</td><td align="left" valign="bottom"/><td align="left" valign="bottom">H1 is a fusion protein of Ag85B <break/>and ESAT-6.<break/>2 µg H1 in 100 μl <break/>CAF01 for immunization <break/>and 1 μg/ml for re-stimulation</td></tr><tr><td align="left" valign="bottom">Peptide, <break/>Recombinant <break/>protein</td><td align="left" valign="bottom">Recombinant murine IL-4</td><td align="left" valign="bottom">PeproTech</td><td align="char" char="ndash" valign="bottom">214–14 B</td><td align="left" valign="bottom">10 μg/ml for in vitro <break/>stimulation</td></tr><tr><td align="left" valign="bottom">Peptide, <break/>Recombinant <break/>protein</td><td align="left" valign="bottom">Purified anti-CD3 e</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">100302</td><td align="left" valign="bottom">0.5 μg/ml re-stimulation</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>C57BL/6 wildtype, MINCLE knockout (<italic>Clec4e<sup>-/-</sup></italic>), FcRγ knockout (<italic>Fcer1g</italic><sup>-/-</sup>), and <italic>Il4<sup>-/-</sup> Il13<sup>-/-</sup></italic> mice were bred under specific pathogen-free conditions at the ‘Präklinische Experimentelle Tierzentrum’ (PETZ) of the Medical Faculty in Erlangen. <italic>Clec4e<sup>-/-</sup></italic> mice were generated by the Consortium for Functional Glycomics (<xref ref-type="bibr" rid="bib71">Wells et al., 2008</xref>) and used with permission. <italic>Fcer1g<sup>-/-</sup></italic> mice (<xref ref-type="bibr" rid="bib65">Takai et al., 1994</xref>) were kindly provided by Dr Falk Nimmerjahn. <italic>Il4<sup>-/-</sup> Il13<sup>-/-</sup></italic> were originally provided by AN McKenzie (MRC Laboratory of Molecular Biology, Cambridge, UK) and backcrossed to CD45.1_C57BL/6 background for more than 10 generations (<xref ref-type="bibr" rid="bib37">McKenzie et al., 1999</xref>). C57BL/6N mice were purchased from Charles River Laboratories. All mouse experiments were approved by the ‘Regierung von Unterfranken’ (protocol number 55.2.2-2532-543) and the ‘Regierung of Oberbayern’ (protocol number ROB-55.2 Vet_02-17-145). Male mice between 8 and 12 weeks of age were used for in vivo experiments.</p></sec><sec id="s4-2"><title>Bacteria</title><p><italic>M. bovis</italic> (BCG) was grown in Middlebrook 7H9 broth supplemented with 10% OADC-enrichment medium and 0.05% Tween 80 in small cell culture flasks constantly shaking at 125 rpm at 37°C to an OD<sub>600</sub> ~1–2. Prior to in vitro stimulation, BCG were washed with PBS and diluted in cDMEM.</p></sec><sec id="s4-3"><title>Hydrodynamic injection of IL-4 minicircle DNA</title><p>To investigate IL-4-derived effects on immunization responses or BCG infections in mice, we utilized a technique that leads to a systemic overexpression of IL-4. A minicircle DNA vector that encodes the gene for IL-4, but lacks further bacterial elements in comparison to conventional plasmids, was hydrodynamically injected intravenously in the tail vein of 5-week-old male mice (<xref ref-type="bibr" rid="bib34">Liu et al., 1999</xref>); 0.5 µg of IL-4 was injected in 2 ml Ringer solution in under 10 s per mouse.</p></sec><sec id="s4-4"><title>Helminth infections</title><p>All <italic>S. mansoni</italic> infection experiments were performed at TU Munich. C57BL/6 mice were infected subcutaneously as described previously (<xref ref-type="bibr" rid="bib10">Bhattacharjee et al., 2019</xref>) with 100 cercariae from the NMRI strain (originally from Puerto Rico) of <italic>S. mansoni</italic> in 100 µl PBS shed by infected <italic>Biomphalaria glabrata</italic> snails, provided by the NIAID Schistosomiasis Resource Center of Biomedical Research Institute (Rockville, MD) through NIH-NIAID Contract HHSN272201700014I for distribution through BEI Resources. Mice were vaccinated after 8 weeks of infection, when parasite egg-induced Th2 immune responses begin to peak.</p><p>The <italic>N. brasiliensis</italic> life cycle was maintained in rats. <italic>N. brasiliensis</italic> larvae were cultured in a mixture of charcoal and feces of infected rats in petri dishes for 15–40 days at room temperature. Subsequently, third-stage (L3) larvae were harvested with 10 ml of 0.9% saline and transferred to a Baermann apparatus. Within 1 hr larvae descended to the bottom of the funnel. Larvae were then transferred to a fresh 50 ml tube and extensively washed by repeating steps of sedimentation and exchange of saline. C57BL/6 mice were infected subcutaneously with 500 L3 larvae in 200 µl PBS in the flank of each mouse using a 25 G needle. All worms were expelled completely within 10 days.</p></sec><sec id="s4-5"><title>BCG infection of mice</title><p>Ten days after <italic>N. brasiliensis</italic> infection, or 2 days after hydrodynamic injection of IL-4 minicircle DNA, mice were infected intraperitoneally with 40×10<sup>6</sup> CFU of <italic>M. bovis</italic> BCG in a volume of 200 µl PBS using a 27 G needle. PBS-injected mice as well as completely naïve mice were used as controls. Mice were sacrificed 24 hr post infection.</p></sec><sec id="s4-6"><title>Immunizations</title><p>Mice were immunized subcutaneously with 50 µl of a mixture of 1 µg H1, a fusion protein of the MTB antigens Ag85B and ESAT-6, and the respective adjuvants (CAF01, CpG ODN 1826, or G3D6A) in the footpads of the hind legs or in the flank as indicated in the figure legends. CAF01 is composed of TDB and cationic dimethyldioctadecylammonium (DDA) liposomes and has been described in detail before (<xref ref-type="bibr" rid="bib2">Agger et al., 2008</xref>). CpG ODN 1826 is a phosphorothioate-protected oligonucleotide and was synthesized by TIB MOLBIOL (Berlin, Germany). G3D6A is a liposomal adjuvant formulation. It is comprised of the synthetic TLR4 ligand 3-<italic>O</italic>-de-acyl-hexaacyl-monophoshoryl lipid A (3D-6A-SMPLA, 3D(6-acyl)-PHAD) manufactured as cGMP product by Avanti Polar Lipids Inc (Alabaster, AL, USA) and embedded in a matrix of 1,2-dimyristoyl-<italic>sn</italic>-glycero-3-phosphocholine, 1,2-dimyristoyl-<italic>sn</italic>-glycero-3-phosphoglycerol and cholesterol (molar ration: 9:1:7.5) in an aqueous suspension buffered with PBS. Footpad swelling was monitored regularly and measured prior to immunization as well as every second day post immunization. On day 7 post immunization, inguinal and popliteal lymph nodes were analysed.</p></sec><sec id="s4-7"><title>Isolation and culture of BMM</title><p>Bone marrow cells were differentiated to BMM for 6–7 days in complete Dulbecco’s modified Eagle medium containing 10% FCS, 50 μM β-mercaptoethanol, and penicillin/streptomycin (cDMEM) supplemented with 10% L929 cell-conditioned medium as a source of M-CSF.</p></sec><sec id="s4-8"><title>Stimulation of BMM</title><p>BMM were stimulated with plate-coated TDB (Polar Avanti, 5 µg/ml), using isopropanol as a mock control, as described (<xref ref-type="bibr" rid="bib72">Werninghaus et al., 2009</xref>), LPS (<italic>Escherichia coli</italic> serotype O55:B5, Sigma, 10 ng/ml), CpG ODN 1826 (TIB MOLBIOL, 0.5 µM), or with BCG at the indicated MOI.</p></sec><sec id="s4-9"><title>Re-stimulation of lymph node cells</title><p>Inguinal and popliteal lymph nodes were collected and meshed through a 70 µm nylon filter to get a single-cell suspension. 5×10<sup>5</sup> cells were stimulated in 96-well U-bottom plates with H1 (1 µg/ml), soluble anti-CD3 (0.5 µg/ml), or left untreated (mock) for 96 hr.</p></sec><sec id="s4-10"><title>mRNA expression of CLR</title><p>RNA was isolated using Trifast (Peqlab) and transcribed to cDNA (High capacity cDNA Reverse Transcription Kit, Applied Biosystems). Expression of the house keeping gene <italic>Hprt</italic> and of the genes of interest was analysed by qRT-PCR. All primers and probes were selected from the Roche Universal Probe Library. Ct values of the target genes were normalized to <italic>Hprt</italic>, calibrated to unstimulated cells, and depicted as fold change.</p></sec><sec id="s4-11"><title>Cytokine ELISA</title><p>Secreted cytokines were analysed by ELISA (R&amp;D Systems) from cell culture supernatants of stimulated BMM or lymph node cells.</p></sec><sec id="s4-12"><title>Flow cytometry</title><p>Cell surface expression of MINCLE was analysed by flow cytometry. Cells were blocked with anti-mouse CD16/32, stained with the primary antibody anti-MINCLE (clone 4A9, MBL, 1 µg/ml), followed by anti-rat IgG1-APC (eBioscience). FACS data were acquired on an LSRFortessa (BD) and analysed using the software FlowJo (v10).</p></sec><sec id="s4-13"><title>Statistics</title><p>GraphPad Prism software (version 8) was used for statistical analysis. Statistical significance was calculated using Mann-Whitney U-test to compare two non-paired groups or Wilcoxon signed rank test for paired groups. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ns p&gt;0.05.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Validation, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Resources</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources</p></fn><fn fn-type="con" id="con11"><p>Resources</p></fn><fn fn-type="con" id="con12"><p>Formal analysis, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Resources, Formal analysis, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Visualization, Writing - original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All mouse experiments were approved by the &quot;Regierung von Unterfranken&quot; (protocol number 55.2.2-2532-543) and the &quot;Regierung of Oberbayern&quot; (protocol number ROB-55.2 Vet_02-17-145).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-72923-transrepform1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>For most figures, the data are directly shown as individual data points. These quantitative data are provided in the accompanying Excel files &quot;Source data Schick et al.xls&quot;.</p></sec><ack id="ack"><title>Acknowledgements</title><p>Animal husbandry by Manfred Kirsch, technical assistance by Nina Grohmann, and support by Christian Bogdan are gratefully acknowledged. We thank Nathalie Thuma and Paul Haase for help with <italic>N. brasiliensis</italic> infections. This work was funded by Deutsche Forschungsgemeinschaft (GRK 1660-TP-A02 and LA 1262/8-1 to RL, and CRC1181_A02 to DV, and CO 1469/16-1 to CPdC).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abate</surname><given-names>E</given-names></name><name><surname>Belayneh</surname><given-names>M</given-names></name><name><surname>Idh</surname><given-names>J</given-names></name><name><surname>Diro</surname><given-names>E</given-names></name><name><surname>Elias</surname><given-names>D</given-names></name><name><surname>Britton</surname><given-names>S</given-names></name><name><surname>Aseffa</surname><given-names>A</given-names></name><name><surname>Stendahl</surname><given-names>O</given-names></name><name><surname>Schön</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Asymptomatic helminth infection in active tuberculosis is associated with increased regulatory and Th-2 responses and a lower sputum smear positivity</article-title><source>PLOS Neglected Tropical Diseases</source><volume>9</volume><elocation-id>e0003994</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0003994</pub-id><pub-id pub-id-type="pmid">26248316</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agger</surname><given-names>EM</given-names></name><name><surname>Rosenkrands</surname><given-names>I</given-names></name><name><surname>Hansen</surname><given-names>J</given-names></name><name><surname>Brahimi</surname><given-names>K</given-names></name><name><surname>Vandahl</surname><given-names>BS</given-names></name><name><surname>Aagaard</surname><given-names>C</given-names></name><name><surname>Werninghaus</surname><given-names>K</given-names></name><name><surname>Kirschning</surname><given-names>C</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name><name><surname>Christensen</surname><given-names>D</given-names></name><name><surname>Theisen</surname><given-names>M</given-names></name><name><surname>Follmann</surname><given-names>F</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e3116</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003116</pub-id><pub-id pub-id-type="pmid">18776936</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arce</surname><given-names>I</given-names></name><name><surname>Martínez-Muñoz</surname><given-names>L</given-names></name><name><surname>Roda-Navarro</surname><given-names>P</given-names></name><name><surname>Fernández-Ruiz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The human C-type lectin CLECSF8 is a novel monocyte/macrophage endocytic receptor</article-title><source>European Journal of Immunology</source><volume>34</volume><fpage>210</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1002/eji.200324230</pub-id><pub-id pub-id-type="pmid">14971047</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>S</given-names></name><name><surname>Blauvelt</surname><given-names>CP</given-names></name><name><surname>Kumaraswami</surname><given-names>V</given-names></name><name><surname>Nutman</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation</article-title><source>Journal of Immunology</source><volume>175</volume><fpage>1170</fpage><lpage>1176</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.2.1170</pub-id><pub-id pub-id-type="pmid">16002719</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>S</given-names></name><name><surname>Bhat</surname><given-names>SQ</given-names></name><name><surname>Kumar</surname><given-names>NP</given-names></name><name><surname>Anuradha</surname><given-names>R</given-names></name><name><surname>Kumaran</surname><given-names>P</given-names></name><name><surname>Gopi</surname><given-names>PG</given-names></name><name><surname>Kolappan</surname><given-names>C</given-names></name><name><surname>Kumaraswami</surname><given-names>V</given-names></name><name><surname>Nutman</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy</article-title><source>PLOS Neglected Tropical Diseases</source><volume>3</volume><elocation-id>e489</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0000489</pub-id><pub-id pub-id-type="pmid">19636364</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>S</given-names></name><name><surname>Bhat</surname><given-names>SQ</given-names></name><name><surname>Kumar</surname><given-names>NP</given-names></name><name><surname>Jayantasri</surname><given-names>S</given-names></name><name><surname>Rukmani</surname><given-names>S</given-names></name><name><surname>Kumaran</surname><given-names>P</given-names></name><name><surname>Gopi</surname><given-names>PG</given-names></name><name><surname>Kolappan</surname><given-names>C</given-names></name><name><surname>Kumaraswami</surname><given-names>V</given-names></name><name><surname>Nutman</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1</article-title><source>The Journal of Infectious Diseases</source><volume>200</volume><fpage>288</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1086/599797</pub-id><pub-id pub-id-type="pmid">19505258</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>S</given-names></name><name><surname>Nutman</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Helminth-tuberculosis co-infection: an immunologic perspective</article-title><source>Trends in Immunology</source><volume>37</volume><fpage>597</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1016/j.it.2016.07.005</pub-id><pub-id pub-id-type="pmid">27501916</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behler</surname><given-names>F</given-names></name><name><surname>Steinwede</surname><given-names>K</given-names></name><name><surname>Balboa</surname><given-names>L</given-names></name><name><surname>Ueberberg</surname><given-names>B</given-names></name><name><surname>Maus</surname><given-names>R</given-names></name><name><surname>Kirchhof</surname><given-names>G</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Welte</surname><given-names>T</given-names></name><name><surname>Maus</surname><given-names>UA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Role of mincle in alveolar macrophage-dependent innate immunity against mycobacterial infections in mice</article-title><source>Journal of Immunology</source><volume>189</volume><fpage>3121</fpage><lpage>3129</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1201399</pub-id><pub-id pub-id-type="pmid">22869905</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behler</surname><given-names>F</given-names></name><name><surname>Maus</surname><given-names>R</given-names></name><name><surname>Bohling</surname><given-names>J</given-names></name><name><surname>Knippenberg</surname><given-names>S</given-names></name><name><surname>Kirchhof</surname><given-names>G</given-names></name><name><surname>Nagata</surname><given-names>M</given-names></name><name><surname>Jonigk</surname><given-names>D</given-names></name><name><surname>Izykowski</surname><given-names>N</given-names></name><name><surname>Mägel</surname><given-names>L</given-names></name><name><surname>Welte</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Maus</surname><given-names>UA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Macrophage-inducible C-type lectin mincle-expressing dendritic cells contribute to control of splenic Mycobacterium bovis BCG infection in mice</article-title><source>Infection and Immunity</source><volume>83</volume><fpage>184</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1128/IAI.02500-14</pub-id><pub-id pub-id-type="pmid">25332121</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharjee</surname><given-names>S</given-names></name><name><surname>Mejías-Luque</surname><given-names>R</given-names></name><name><surname>Loffredo-Verde</surname><given-names>E</given-names></name><name><surname>Toska</surname><given-names>A</given-names></name><name><surname>Flossdorf</surname><given-names>M</given-names></name><name><surname>Gerhard</surname><given-names>M</given-names></name><name><surname>Prazeres da Costa</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Concomitant infection of S. mansoni and H. pylori promotes promiscuity of antigen-experienced cells and primes the liver for a lower fibrotic response</article-title><source>Cell Reports</source><volume>28</volume><fpage>231</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.05.108</pub-id><pub-id pub-id-type="pmid">31269443</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Brewer</surname><given-names>TF</given-names></name><name><surname>Berkey</surname><given-names>CS</given-names></name><name><surname>Wilson</surname><given-names>ME</given-names></name><name><surname>Burdick</surname><given-names>E</given-names></name><name><surname>Fineberg</surname><given-names>HV</given-names></name><name><surname>Mosteller</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature</article-title><source>JAMA</source><volume>271</volume><fpage>698</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">8309034</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desel</surname><given-names>C</given-names></name><name><surname>Werninghaus</surname><given-names>K</given-names></name><name><surname>Ritter</surname><given-names>M</given-names></name><name><surname>Jozefowski</surname><given-names>K</given-names></name><name><surname>Wenzel</surname><given-names>J</given-names></name><name><surname>Russkamp</surname><given-names>N</given-names></name><name><surname>Schleicher</surname><given-names>U</given-names></name><name><surname>Christensen</surname><given-names>D</given-names></name><name><surname>Wirtz</surname><given-names>S</given-names></name><name><surname>Kirschning</surname><given-names>C</given-names></name><name><surname>Agger</surname><given-names>EM</given-names></name><name><surname>Prazeres da Costa</surname><given-names>C</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e53531</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053531</pub-id><pub-id pub-id-type="pmid">23308247</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Desel</surname><given-names>C</given-names></name><name><surname>Yeremeev</surname><given-names>V</given-names></name><name><surname>Pradl</surname><given-names>L</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><name><surname>Mollenkopf</surname><given-names>H-J</given-names></name><name><surname>Hanke</surname><given-names>K</given-names></name><name><surname>Gross</surname><given-names>O</given-names></name><name><surname>Ruland</surname><given-names>J</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The adaptor molecule CARD9 is essential for tuberculosis control</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>777</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1084/jem.20090067</pub-id><pub-id pub-id-type="pmid">20351059</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elias</surname><given-names>D</given-names></name><name><surname>Wolday</surname><given-names>D</given-names></name><name><surname>Akuffo</surname><given-names>H</given-names></name><name><surname>Petros</surname><given-names>B</given-names></name><name><surname>Bronner</surname><given-names>U</given-names></name><name><surname>Britton</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after Bacille Calmette-Guérin (BCG) vaccination</article-title><source>Clinical and Experimental Immunology</source><volume>123</volume><fpage>219</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.2001.01446.x</pub-id><pub-id pub-id-type="pmid">11207651</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elias</surname><given-names>D</given-names></name><name><surname>Akuffo</surname><given-names>H</given-names></name><name><surname>Pawlowski</surname><given-names>A</given-names></name><name><surname>Haile</surname><given-names>M</given-names></name><name><surname>Schön</surname><given-names>T</given-names></name><name><surname>Britton</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis</article-title><source>Vaccine</source><volume>23</volume><fpage>1326</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2004.09.038</pub-id><pub-id pub-id-type="pmid">15661380</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elias</surname><given-names>D</given-names></name><name><surname>Mengistu</surname><given-names>G</given-names></name><name><surname>Akuffo</surname><given-names>H</given-names></name><name><surname>Britton</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Are intestinal helminths risk factors for developing active tuberculosis?</article-title><source>Tropical Medicine &amp; International Health</source><volume>11</volume><fpage>551</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3156.2006.01578.x</pub-id><pub-id pub-id-type="pmid">16553939</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Classon</surname><given-names>C</given-names></name><name><surname>Teran</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Atrophy of skin-draining lymph nodes predisposes for impaired immune responses to secondary infection in mice with chronic intestinal nematode infection</article-title><source>PLOS Pathog</source><volume>14</volume><elocation-id>e1007008</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007008</pub-id><pub-id pub-id-type="pmid">29772005</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>A</given-names></name><name><surname>Kamishikiryo</surname><given-names>J</given-names></name><name><surname>Mori</surname><given-names>D</given-names></name><name><surname>Toyonaga</surname><given-names>K</given-names></name><name><surname>Okabe</surname><given-names>Y</given-names></name><name><surname>Toji</surname><given-names>A</given-names></name><name><surname>Kanda</surname><given-names>R</given-names></name><name><surname>Miyake</surname><given-names>Y</given-names></name><name><surname>Ose</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Maenaka</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural analysis for glycolipid recognition by the C-type lectins mincle and MCL</article-title><source>PNAS</source><volume>110</volume><fpage>17438</fpage><lpage>17443</lpage><pub-id pub-id-type="doi">10.1073/pnas.1312649110</pub-id><pub-id pub-id-type="pmid">24101491</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebreegziabiher</surname><given-names>D</given-names></name><name><surname>Desta</surname><given-names>K</given-names></name><name><surname>Desalegn</surname><given-names>G</given-names></name><name><surname>Howe</surname><given-names>R</given-names></name><name><surname>Abebe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The effect of maternal helminth infection on maternal and neonatal immune function and immunity to tuberculosis</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e93429</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0093429</pub-id><pub-id pub-id-type="pmid">24710174</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geijtenbeek</surname><given-names>TBH</given-names></name><name><surname>Van Vliet</surname><given-names>SJ</given-names></name><name><surname>Koppel</surname><given-names>EA</given-names></name><name><surname>Sanchez-Hernandez</surname><given-names>M</given-names></name><name><surname>Vandenbroucke-Grauls</surname><given-names>CMJE</given-names></name><name><surname>Appelmelk</surname><given-names>B</given-names></name><name><surname>Van Kooyk</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mycobacteria target DC-SIGN to suppress dendritic cell function</article-title><source>The Journal of Experimental Medicine</source><volume>197</volume><fpage>7</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1084/jem.20021229</pub-id><pub-id pub-id-type="pmid">12515809</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geisel</surname><given-names>RE</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Rhoades</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>In vivo activity of released cell wall lipids of mycobacterium bovis bacillus calmette-guérin is due principally to trehalose mycolates</article-title><source>Journal of Immunology</source><volume>174</volume><fpage>5007</fpage><lpage>5015</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.8.5007</pub-id><pub-id pub-id-type="pmid">15814731</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>PJ</given-names></name><name><surname>Anuradha</surname><given-names>R</given-names></name><name><surname>Kumaran</surname><given-names>PP</given-names></name><name><surname>Chandrasekaran</surname><given-names>V</given-names></name><name><surname>Nutman</surname><given-names>TB</given-names></name><name><surname>Babu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Modulation of mycobacterial-specific th1 and th17 cells in latent tuberculosis by coincident hookworm infection</article-title><source>Journal of Immunology</source><volume>190</volume><fpage>5161</fpage><lpage>5168</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203311</pub-id><pub-id pub-id-type="pmid">23576678</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Obermajer</surname><given-names>N</given-names></name><name><surname>Slight</surname><given-names>S</given-names></name><name><surname>Nuthalapati</surname><given-names>N</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><name><surname>Kalinski</surname><given-names>P</given-names></name><name><surname>Khader</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>IL-23-dependent IL-17 drives th1-cell responses following mycobacterium bovis BCG vaccination</article-title><source>European Journal of Immunology</source><volume>42</volume><fpage>364</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1002/eji.201141569</pub-id><pub-id pub-id-type="pmid">22101830</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>LM</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Schafer</surname><given-names>G</given-names></name><name><surname>Reid</surname><given-names>DM</given-names></name><name><surname>Kimberg</surname><given-names>M</given-names></name><name><surname>Dennehy</surname><given-names>KM</given-names></name><name><surname>Hornsell</surname><given-names>WG</given-names></name><name><surname>Guler</surname><given-names>R</given-names></name><name><surname>Campanero-Rhodes</surname><given-names>MA</given-names></name><name><surname>Palma</surname><given-names>AS</given-names></name><name><surname>Feizi</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Sobieszczuk</surname><given-names>P</given-names></name><name><surname>Willment</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The C-type lectin receptor CLECSF8 (CLEC4D) is expressed by myeloid cells and triggers cellular activation through Syk kinase</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>25964</fpage><lpage>25974</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.384164</pub-id><pub-id pub-id-type="pmid">22689578</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrington</surname><given-names>LE</given-names></name><name><surname>Hatton</surname><given-names>RD</given-names></name><name><surname>Mangan</surname><given-names>PR</given-names></name><name><surname>Turner</surname><given-names>H</given-names></name><name><surname>Murphy</surname><given-names>TL</given-names></name><name><surname>Murphy</surname><given-names>KM</given-names></name><name><surname>Weaver</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages</article-title><source>Nature Immunology</source><volume>6</volume><fpage>1123</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1038/ni1254</pub-id><pub-id pub-id-type="pmid">16200070</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hupfer</surname><given-names>T</given-names></name><name><surname>Schick</surname><given-names>J</given-names></name><name><surname>Jozefowski</surname><given-names>K</given-names></name><name><surname>Voehringer</surname><given-names>D</given-names></name><name><surname>Ostrop</surname><given-names>J</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Stat6-Dependent inhibition of Mincle expression in mouse and human antigen-presenting cells by the Th2 cytokine IL-4</article-title><source>Frontiers in Immunology</source><volume>7</volume><elocation-id>423</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00423</pub-id><pub-id pub-id-type="pmid">27790218</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ifrim</surname><given-names>DC</given-names></name><name><surname>Bain</surname><given-names>JM</given-names></name><name><surname>Reid</surname><given-names>DM</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Verschueren</surname><given-names>I</given-names></name><name><surname>Gow</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of dectin-2 for host defense against systemic infection with candida glabrata</article-title><source>Infect Immun</source><volume>82</volume><fpage>1064</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1128/IAI.01189-13</pub-id><pub-id pub-id-type="pmid">24343653</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>E</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Morita</surname><given-names>YS</given-names></name><name><surname>Toyonaga</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Yoshikai</surname><given-names>Y</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle</article-title><source>The Journal of Experimental Medicine</source><volume>206</volume><fpage>2879</fpage><lpage>2888</lpage><pub-id pub-id-type="doi">10.1084/jem.20091750</pub-id><pub-id pub-id-type="pmid">20008526</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>E</given-names></name><name><surname>Mori</surname><given-names>D</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Recognition of mycobacterial lipids by immune receptors</article-title><source>Trends in Immunology</source><volume>38</volume><fpage>66</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.it.2016.10.009</pub-id><pub-id pub-id-type="pmid">27889398</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>R</given-names></name><name><surname>Schick</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Review: impact of helminth infection on antimycobacterial immunity-A focus on the macrophage</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>1864</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.01864</pub-id><pub-id pub-id-type="pmid">29312343</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W-B</given-names></name><name><surname>Kang</surname><given-names>J-S</given-names></name><name><surname>Yan</surname><given-names>J-J</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Jeon</surname><given-names>B-Y</given-names></name><name><surname>Cho</surname><given-names>S-N</given-names></name><name><surname>Kim</surname><given-names>Y-J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neutrophils promote mycobacterial trehalose dimycolate-induced lung inflammation via the Mincle pathway</article-title><source>PLOS Pathogens</source><volume>8</volume><elocation-id>e1002614</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002614</pub-id><pub-id pub-id-type="pmid">22496642</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindenstrøm</surname><given-names>T</given-names></name><name><surname>Agger</surname><given-names>EM</given-names></name><name><surname>Korsholm</surname><given-names>KS</given-names></name><name><surname>Darrah</surname><given-names>PA</given-names></name><name><surname>Aagaard</surname><given-names>C</given-names></name><name><surname>Seder</surname><given-names>RA</given-names></name><name><surname>Rosenkrands</surname><given-names>I</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells</article-title><source>Journal of Immunology</source><volume>182</volume><fpage>8047</fpage><lpage>8055</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0801592</pub-id><pub-id pub-id-type="pmid">19494330</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindenstrøm</surname><given-names>T</given-names></name><name><surname>Woodworth</surname><given-names>J</given-names></name><name><surname>Dietrich</surname><given-names>J</given-names></name><name><surname>Aagaard</surname><given-names>C</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Agger</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Vaccine-Induced Th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset</article-title><source>Infection and Immunity</source><volume>80</volume><fpage>3533</fpage><lpage>3544</lpage><pub-id pub-id-type="doi">10.1128/IAI.00550-12</pub-id><pub-id pub-id-type="pmid">22851756</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Hydrodynamics-Based transfection in animals by systemic administration of plasmid DNA</article-title><source>Gene Therapy</source><volume>6</volume><fpage>1258</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1038/sj.gt.3300947</pub-id><pub-id pub-id-type="pmid">10455434</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>I</given-names></name><name><surname>Mungai</surname><given-names>P</given-names></name><name><surname>Wamachi</surname><given-names>A</given-names></name><name><surname>Kioko</surname><given-names>J</given-names></name><name><surname>Ouma</surname><given-names>JH</given-names></name><name><surname>Kazura</surname><given-names>JW</given-names></name><name><surname>King</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Helminth- and Bacillus calmette-guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis</article-title><source>The Journal of Immunology</source><volume>162</volume><fpage>6843</fpage><lpage>6848</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.162.11.6843</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Kaisho</surname><given-names>T</given-names></name><name><surname>Sanjo</surname><given-names>H</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Gilbert</surname><given-names>DJ</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A novel LPS-inducible C-type lectin is A transcriptional target of NF-IL6 in macrophages</article-title><source>Journal of Immunology</source><volume>163</volume><fpage>5039</fpage><lpage>5048</lpage><pub-id pub-id-type="pmid">10528209</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>GJ</given-names></name><name><surname>Fallon</surname><given-names>PG</given-names></name><name><surname>Emson</surname><given-names>CL</given-names></name><name><surname>Grencis</surname><given-names>RK</given-names></name><name><surname>McKenzie</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses</article-title><source>J Exp Med</source><volume>1</volume><fpage>1565</fpage><lpage>1572</lpage><pub-id pub-id-type="doi">10.1084/jem.189.10.1565</pub-id><pub-id pub-id-type="pmid">10330435</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melo</surname><given-names>MD</given-names></name><name><surname>Catchpole</surname><given-names>IR</given-names></name><name><surname>Haggar</surname><given-names>G</given-names></name><name><surname>Stokes</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Utilization of cd11b knockout mice to characterize the role of complement receptor 3 (CR3, cd11b/CD18) in the growth of mycobacterium tuberculosis in macrophages</article-title><source>Cellular Immunology</source><volume>205</volume><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1006/cimm.2000.1710</pub-id><pub-id pub-id-type="pmid">11078603</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>Y</given-names></name><name><surname>Toyonaga</surname><given-names>K</given-names></name><name><surname>Mori</surname><given-names>D</given-names></name><name><surname>Kakuta</surname><given-names>S</given-names></name><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Oyamada</surname><given-names>A</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>K-I</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Iwakura</surname><given-names>Y</given-names></name><name><surname>Yoshikai</surname><given-names>Y</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>C-Type lectin MCL is an fcrγ-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor</article-title><source>Immunity</source><volume>38</volume><fpage>1050</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.03.010</pub-id><pub-id pub-id-type="pmid">23602766</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monin</surname><given-names>L</given-names></name><name><surname>Griffiths</surname><given-names>KL</given-names></name><name><surname>Slight</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name><surname>Khader</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune requirements for protective th17 recall responses to mycobacterium tuberculosis challenge</article-title><source>Mucosal Immunology</source><volume>8</volume><fpage>1099</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1038/mi.2014.136</pub-id><pub-id pub-id-type="pmid">25627812</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortaz</surname><given-names>E</given-names></name><name><surname>Adcock</surname><given-names>IM</given-names></name><name><surname>Tabarsi</surname><given-names>P</given-names></name><name><surname>Masjedi</surname><given-names>MR</given-names></name><name><surname>Mansouri</surname><given-names>D</given-names></name><name><surname>Velayati</surname><given-names>AA</given-names></name><name><surname>Casanova</surname><given-names>J-L</given-names></name><name><surname>Barnes</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interaction of pattern recognition receptors with mycobacterium tuberculosis</article-title><source>Journal of Clinical Immunology</source><volume>35</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s10875-014-0103-7</pub-id><pub-id pub-id-type="pmid">25312698</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>N</given-names></name><name><surname>Olsen</surname><given-names>AW</given-names></name><name><surname>Lorenzen</surname><given-names>E</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Hvid</surname><given-names>M</given-names></name><name><surname>Follmann</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Parenteral vaccination protects against transcervical infection with <italic>Chlamydia trachomatis</italic> and generate tissue-resident T cells post-challenge</article-title><source>NPJ Vaccines</source><volume>5</volume><elocation-id>e57</elocation-id><pub-id pub-id-type="doi">10.1038/s41541-020-0157-x</pub-id><pub-id pub-id-type="pmid">31993218</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obieglo</surname><given-names>K</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Bollampalli</surname><given-names>VP</given-names></name><name><surname>Dellacasa-Lindberg</surname><given-names>I</given-names></name><name><surname>Classon</surname><given-names>C</given-names></name><name><surname>Österblad</surname><given-names>M</given-names></name><name><surname>Helmby</surname><given-names>H</given-names></name><name><surname>Hewitson</surname><given-names>JP</given-names></name><name><surname>Maizels</surname><given-names>RM</given-names></name><name><surname>Gigliotti Rothfuchs</surname><given-names>A</given-names></name><name><surname>Nylén</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Chronic gastrointestinal nematode infection mutes immune responses to mycobacterial infection distal to the gut</article-title><source>Journal of Immunology</source><volume>196</volume><fpage>2262</fpage><lpage>2271</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500970</pub-id><pub-id pub-id-type="pmid">26819205</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostrop</surname><given-names>J</given-names></name><name><surname>Jozefowski</surname><given-names>K</given-names></name><name><surname>Zimmermann</surname><given-names>S</given-names></name><name><surname>Hofmann</surname><given-names>K</given-names></name><name><surname>Strasser</surname><given-names>E</given-names></name><name><surname>Lepenies</surname><given-names>B</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Contribution of MINCLE-SYK signaling to activation of primary human APCS by mycobacterial cord factor and the novel adjuvant TDB</article-title><source>Journal of Immunology</source><volume>195</volume><fpage>2417</fpage><lpage>2428</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500102</pub-id><pub-id pub-id-type="pmid">26202982</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostrop</surname><given-names>J</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Contact, collaboration, and conflict: signal integration of syk-coupled C-type lectin receptors</article-title><source>Journal of Immunology</source><volume>198</volume><fpage>1403</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601665</pub-id><pub-id pub-id-type="pmid">28167651</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname><given-names>M</given-names></name><name><surname>Behr</surname><given-names>MA</given-names></name><name><surname>Dowdy</surname><given-names>D</given-names></name><name><surname>Dheda</surname><given-names>K</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Boehme</surname><given-names>CC</given-names></name><name><surname>Ginsberg</surname><given-names>A</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Spigelman</surname><given-names>M</given-names></name><name><surname>Getahun</surname><given-names>H</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name><name><surname>Raviglione</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tuberculosis</article-title><source>Nature Reviews. Disease Primers</source><volume>2</volume><elocation-id>16076</elocation-id><pub-id pub-id-type="doi">10.1038/nrdp.2016.76</pub-id><pub-id pub-id-type="pmid">27784885</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paludan</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship</article-title><source>Scandinavian Journal of Immunology</source><volume>48</volume><fpage>459</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1046/j.1365-3083.1998.00435.x</pub-id><pub-id pub-id-type="pmid">9822252</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>XO</given-names></name><name><surname>Chang</surname><given-names>SH</given-names></name><name><surname>Nurieva</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Y-H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hood</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Tian</surname><given-names>Q</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17</article-title><source>Nature Immunology</source><volume>6</volume><fpage>1133</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1038/ni1261</pub-id><pub-id pub-id-type="pmid">16200068</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potian</surname><given-names>JA</given-names></name><name><surname>Rafi</surname><given-names>W</given-names></name><name><surname>Bhatt</surname><given-names>K</given-names></name><name><surname>McBride</surname><given-names>A</given-names></name><name><surname>Gause</surname><given-names>WC</given-names></name><name><surname>Salgame</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway</article-title><source>The Journal of Experimental Medicine</source><volume>208</volume><fpage>1863</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.1084/jem.20091473</pub-id><pub-id pub-id-type="pmid">21825018</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafi</surname><given-names>W</given-names></name><name><surname>Bhatt</surname><given-names>K</given-names></name><name><surname>Gause</surname><given-names>WC</given-names></name><name><surname>Salgame</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neither primary nor memory immunity to Mycobacterium tuberculosis infection is compromised in mice with chronic enteric helminth infection</article-title><source>Infection and Immunity</source><volume>83</volume><fpage>1217</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.1128/IAI.03004-14</pub-id><pub-id pub-id-type="pmid">25605766</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajaram</surname><given-names>MVS</given-names></name><name><surname>Arnett</surname><given-names>E</given-names></name><name><surname>Azad</surname><given-names>AK</given-names></name><name><surname>Guirado</surname><given-names>E</given-names></name><name><surname>Ni</surname><given-names>B</given-names></name><name><surname>Gerberick</surname><given-names>AD</given-names></name><name><surname>He</surname><given-names>L-Z</given-names></name><name><surname>Keler</surname><given-names>T</given-names></name><name><surname>Thomas</surname><given-names>LJ</given-names></name><name><surname>Lafuse</surname><given-names>WP</given-names></name><name><surname>Schlesinger</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>M. tuberculosis-initiated human mannose receptor signaling regulates macrophage recognition and vesicle trafficking by fcrγ-chain, Grb2, and SHP-1</article-title><source>Cell Reports</source><volume>21</volume><fpage>126</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.034</pub-id><pub-id pub-id-type="pmid">28978467</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinink</surname><given-names>P</given-names></name><name><surname>Buter</surname><given-names>J</given-names></name><name><surname>Mishra</surname><given-names>VK</given-names></name><name><surname>Ishikawa</surname><given-names>E</given-names></name><name><surname>Cheng</surname><given-names>TY</given-names></name><name><surname>Willemsen</surname><given-names>PTJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Discovery of salmonella trehalose phospholipids reveals functional convergence with mycobacteria</article-title><source>J Exp Med</source><volume>216</volume><fpage>757</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1084/jem.20181812</pub-id><pub-id pub-id-type="pmid">30804000</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resende Co</surname><given-names>T</given-names></name><name><surname>Hirsch</surname><given-names>CS</given-names></name><name><surname>Toossi</surname><given-names>Z</given-names></name><name><surname>Dietze</surname><given-names>R</given-names></name><name><surname>Ribeiro-Rodrigues</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy</article-title><source>Clinical and Experimental Immunology</source><volume>147</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03247.x</pub-id><pub-id pub-id-type="pmid">17177962</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>NC</given-names></name><name><surname>Slack</surname><given-names>EC</given-names></name><name><surname>Edwards</surname><given-names>AD</given-names></name><name><surname>Nolte</surname><given-names>MA</given-names></name><name><surname>Schulz</surname><given-names>O</given-names></name><name><surname>Schweighoffer</surname><given-names>E</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Tybulewicz</surname><given-names>VL</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Reis e Sousa</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Syk-Dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins</article-title><source>Immunity</source><volume>22</volume><fpage>507</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2005.03.004</pub-id><pub-id pub-id-type="pmid">15845454</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothfuchs</surname><given-names>AG</given-names></name><name><surname>Bafica</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Egen</surname><given-names>JG</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dectin-1 interaction with mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells</article-title><source>Journal of Immunology</source><volume>179</volume><fpage>3463</fpage><lpage>3471</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.6.3463</pub-id><pub-id pub-id-type="pmid">17785780</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Eisenhut</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>RJ</given-names></name><name><surname>Rodrigues</surname><given-names>LC</given-names></name><name><surname>Sridhar</surname><given-names>S</given-names></name><name><surname>Habermann</surname><given-names>S</given-names></name><name><surname>Snell</surname><given-names>L</given-names></name><name><surname>Mangtani</surname><given-names>P</given-names></name><name><surname>Adetifa</surname><given-names>I</given-names></name><name><surname>Lalvani</surname><given-names>A</given-names></name><name><surname>Abubakar</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Effect of BCG vaccination against mycobacterium tuberculosis infection in children: systematic review and meta-analysis</article-title><source>BMJ</source><volume>349</volume><elocation-id>g4643</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.g4643</pub-id><pub-id pub-id-type="pmid">25097193</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgame</surname><given-names>P</given-names></name><name><surname>Yap</surname><given-names>GS</given-names></name><name><surname>Gause</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Effect of helminth-induced immunity on infections with microbial pathogens</article-title><source>Nature Immunology</source><volume>14</volume><fpage>1118</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1038/ni.2736</pub-id><pub-id pub-id-type="pmid">24145791</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Yudate</surname><given-names>T</given-names></name><name><surname>Chung</surname><given-names>J-S</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Luby-Phelps</surname><given-names>K</given-names></name><name><surname>Kimberly</surname><given-names>RP</given-names></name><name><surname>Underhill</surname><given-names>D</given-names></name><name><surname>Cruz</surname><given-names>PD</given-names><suffix>Jr</suffix></name><name><surname>Ariizumi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>38854</fpage><lpage>38866</lpage><pub-id pub-id-type="doi">10.1074/jbc.M606542200</pub-id><pub-id pub-id-type="pmid">17050534</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schick</surname><given-names>J</given-names></name><name><surname>Schäfer</surname><given-names>J</given-names></name><name><surname>Alexander</surname><given-names>C</given-names></name><name><surname>Dichtl</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Christensen</surname><given-names>D</given-names></name><name><surname>Sorg</surname><given-names>U</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><name><surname>Schleicher</surname><given-names>U</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cutting edge: TNF is essential for mycobacteria-induced MINCLE expression, macrophage activation, and th17 adjuvanticity</article-title><source>Journal of Immunology</source><volume>205</volume><fpage>323</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.2000420</pub-id><pub-id pub-id-type="pmid">32540999</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenen</surname><given-names>H</given-names></name><name><surname>Bodendorfer</surname><given-names>B</given-names></name><name><surname>Hitchens</surname><given-names>K</given-names></name><name><surname>Manzanero</surname><given-names>S</given-names></name><name><surname>Werninghaus</surname><given-names>K</given-names></name><name><surname>Nimmerjahn</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate</article-title><source>J Immunol</source><volume>184</volume><fpage>2756</fpage><lpage>2760</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0904013</pub-id><pub-id pub-id-type="pmid">20164423</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schramm</surname><given-names>G</given-names></name><name><surname>Suwandi</surname><given-names>A</given-names></name><name><surname>Galeev</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Braun</surname><given-names>J</given-names></name><name><surname>Claes</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Schistosome eggs impair protective th1/th17 immune responses against salmonella infection</article-title><source>Frontiers in Immunology</source><volume>1</volume><elocation-id>e614</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02614</pub-id><pub-id pub-id-type="pmid">30487793</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Gurcha</surname><given-names>SS</given-names></name><name><surname>Jankovic</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Oland</surname><given-names>S</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Ting</surname><given-names>JPY</given-names></name><name><surname>Trinchieri</surname><given-names>G</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><name><surname>Cerundolo</surname><given-names>V</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cord factor and peptidoglycan recapitulate the th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome</article-title><source>Journal of Immunology</source><volume>190</volume><fpage>5722</fpage><lpage>5730</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203343</pub-id><pub-id pub-id-type="pmid">23630357</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stappers</surname><given-names>MHT</given-names></name><name><surname>Nikolakopoulou</surname><given-names>C</given-names></name><name><surname>Wiesner</surname><given-names>DL</given-names></name><name><surname>Yuecel</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>BS</given-names></name><name><surname>Willment</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Characterization of antifungal C-type lectin receptor expression on murine epithelial and endothelial cells in mucosal tissues</article-title><source>European Journal of Immunology</source><volume>51</volume><fpage>2341</fpage><lpage>2344</lpage><pub-id pub-id-type="doi">10.1002/eji.202149192</pub-id><pub-id pub-id-type="pmid">34114658</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suda</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Hydrodynamic gene delivery: its principles and applications</article-title><source>Molecular Therapy</source><volume>15</volume><fpage>2063</fpage><lpage>2069</lpage><pub-id pub-id-type="doi">10.1038/sj.mt.6300314</pub-id><pub-id pub-id-type="pmid">17912237</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takai</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Sylvestre</surname><given-names>D</given-names></name><name><surname>Clynes</surname><given-names>R</given-names></name><name><surname>Ravetch</surname><given-names>JV</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Fcr gamma chain deletion results in pleiotrophic effector cell defects</article-title><source>Cell</source><volume>76</volume><fpage>519</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90115-5</pub-id><pub-id pub-id-type="pmid">8313472</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyonaga</surname><given-names>K</given-names></name><name><surname>Torigoe</surname><given-names>S</given-names></name><name><surname>Motomura</surname><given-names>Y</given-names></name><name><surname>Kamichi</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>JM</given-names></name><name><surname>Morita</surname><given-names>YS</given-names></name><name><surname>Noguchi</surname><given-names>N</given-names></name><name><surname>Chuma</surname><given-names>Y</given-names></name><name><surname>Kiyohara</surname><given-names>H</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Sakuma</surname><given-names>T</given-names></name><name><surname>Ohmuraya</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Umemura</surname><given-names>M</given-names></name><name><surname>Matsuzaki</surname><given-names>G</given-names></name><name><surname>Yoshikai</surname><given-names>Y</given-names></name><name><surname>Yano</surname><given-names>I</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C-Type lectin receptor DCAR recognizes mycobacterial phosphatidyl-inositol mannosides to promote a Th1 response during infection</article-title><source>Immunity</source><volume>45</volume><fpage>1245</fpage><lpage>1257</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.10.012</pub-id><pub-id pub-id-type="pmid">27887882</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tristão-Sá</surname><given-names>R</given-names></name><name><surname>Ribeiro-Rodrigues</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>LT</given-names></name><name><surname>Pereira</surname><given-names>FEL</given-names></name><name><surname>Dietze</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Intestinal nematodes and pulmonary tuberculosis</article-title><source>Revista Da Sociedade Brasileira de Medicina Tropical</source><volume>35</volume><fpage>533</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1590/s0037-86822002000500020</pub-id><pub-id pub-id-type="pmid">12621678</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Vlugt</surname><given-names>LE</given-names></name><name><surname>Labuda</surname><given-names>LA</given-names></name><name><surname>Ozir-Fazalalikhan</surname><given-names>A</given-names></name><name><surname>Lievers</surname><given-names>E</given-names></name><name><surname>Gloudemans</surname><given-names>AK</given-names></name><name><surname>Liu</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Schistosomes induce regulatory features in human and mouse cd1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e30883</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0030883</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhagen</surname><given-names>LM</given-names></name><name><surname>Hermans</surname><given-names>PWM</given-names></name><name><surname>Warris</surname><given-names>A</given-names></name><name><surname>de Groot</surname><given-names>R</given-names></name><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Villalba</surname><given-names>JA</given-names></name><name><surname>del Nogal</surname><given-names>B</given-names></name><name><surname>van den Hof</surname><given-names>S</given-names></name><name><surname>Mughini Gras</surname><given-names>L</given-names></name><name><surname>van Soolingen</surname><given-names>D</given-names></name><name><surname>Pinelli</surname><given-names>E</given-names></name><name><surname>de Waard</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Helminths and skewed cytokine profiles increase tuberculin skin test positivity in warao amerindians</article-title><source>Tuberculosis</source><volume>92</volume><fpage>505</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2012.07.004</pub-id><pub-id pub-id-type="pmid">22877977</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>EL</given-names></name><name><surname>Mawa</surname><given-names>PA</given-names></name><name><surname>Ndibazza</surname><given-names>J</given-names></name><name><surname>Kizito</surname><given-names>D</given-names></name><name><surname>Namatovu</surname><given-names>A</given-names></name><name><surname>Kyosiimire-Lugemwa</surname><given-names>J</given-names></name><name><surname>Nanteza</surname><given-names>B</given-names></name><name><surname>Nampijja</surname><given-names>M</given-names></name><name><surname>Muhangi</surname><given-names>L</given-names></name><name><surname>Woodburn</surname><given-names>PW</given-names></name><name><surname>Akurut</surname><given-names>H</given-names></name><name><surname>Mpairwe</surname><given-names>H</given-names></name><name><surname>Akello</surname><given-names>M</given-names></name><name><surname>Lyadda</surname><given-names>N</given-names></name><name><surname>Bukusuba</surname><given-names>J</given-names></name><name><surname>Kihembo</surname><given-names>M</given-names></name><name><surname>Kizza</surname><given-names>M</given-names></name><name><surname>Kizindo</surname><given-names>R</given-names></name><name><surname>Nabulime</surname><given-names>J</given-names></name><name><surname>Ameke</surname><given-names>C</given-names></name><name><surname>Namujju</surname><given-names>PB</given-names></name><name><surname>Tweyongyere</surname><given-names>R</given-names></name><name><surname>Muwanga</surname><given-names>M</given-names></name><name><surname>Whitworth</surname><given-names>JAG</given-names></name><name><surname>Elliott</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Effect of single-dose anthelmintic treatment during pregnancy on an infant’s response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial</article-title><source>Lancet</source><volume>377</volume><fpage>52</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61457-2</pub-id><pub-id pub-id-type="pmid">21176950</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>CA</given-names></name><name><surname>Salvage-Jones</surname><given-names>JA</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Hitchens</surname><given-names>K</given-names></name><name><surname>Butcher</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>RZ</given-names></name><name><surname>Beckhouse</surname><given-names>AG</given-names></name><name><surname>Lo</surname><given-names>YLS</given-names></name><name><surname>Manzanero</surname><given-names>S</given-names></name><name><surname>Cobbold</surname><given-names>C</given-names></name><name><surname>Schroder</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Orr</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>L</given-names></name><name><surname>Lebus</surname><given-names>D</given-names></name><name><surname>Sobieszczuk</surname><given-names>P</given-names></name><name><surname>Hume</surname><given-names>DA</given-names></name><name><surname>Stow</surname><given-names>J</given-names></name><name><surname>Blanchard</surname><given-names>H</given-names></name><name><surname>Ashman</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to candida albicans</article-title><source>Journal of Immunology</source><volume>180</volume><fpage>7404</fpage><lpage>7413</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.11.7404</pub-id><pub-id pub-id-type="pmid">18490740</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werninghaus</surname><given-names>K</given-names></name><name><surname>Babiak</surname><given-names>A</given-names></name><name><surname>Gross</surname><given-names>O</given-names></name><name><surname>Hölscher</surname><given-names>C</given-names></name><name><surname>Dietrich</surname><given-names>H</given-names></name><name><surname>Agger</surname><given-names>EM</given-names></name><name><surname>Mages</surname><given-names>J</given-names></name><name><surname>Mocsai</surname><given-names>A</given-names></name><name><surname>Schoenen</surname><given-names>H</given-names></name><name><surname>Finger</surname><given-names>K</given-names></name><name><surname>Nimmerjahn</surname><given-names>F</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Kirschning</surname><given-names>C</given-names></name><name><surname>Heit</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>Ruland</surname><given-names>J</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires fcrgamma-syk-card9-dependent innate immune activation</article-title><source>The Journal of Experimental Medicine</source><volume>206</volume><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1084/jem.20081445</pub-id><pub-id pub-id-type="pmid">19139169</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willment</surname><given-names>JA</given-names></name><name><surname>Lin</surname><given-names>HH</given-names></name><name><surname>Reid</surname><given-names>DM</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Wong</surname><given-names>SYC</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide</article-title><source>Journal of Immunology</source><volume>171</volume><fpage>4569</fpage><lpage>4573</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.9.4569</pub-id><pub-id pub-id-type="pmid">14568930</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>GJ</given-names></name><name><surname>Marakalala</surname><given-names>MJ</given-names></name><name><surname>Hoving</surname><given-names>JC</given-names></name><name><surname>van Laarhoven</surname><given-names>A</given-names></name><name><surname>Drummond</surname><given-names>RA</given-names></name><name><surname>Kerscher</surname><given-names>B</given-names></name><name><surname>Keeton</surname><given-names>R</given-names></name><name><surname>van de Vosse</surname><given-names>E</given-names></name><name><surname>Ottenhoff</surname><given-names>THM</given-names></name><name><surname>Plantinga</surname><given-names>TS</given-names></name><name><surname>Alisjahbana</surname><given-names>B</given-names></name><name><surname>Govender</surname><given-names>D</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Reid</surname><given-names>DM</given-names></name><name><surname>Willment</surname><given-names>JA</given-names></name><name><surname>Jacobs</surname><given-names>M</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunity</article-title><source>Cell Host &amp; Microbe</source><volume>17</volume><fpage>252</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.01.004</pub-id><pub-id pub-id-type="pmid">25674984</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Ishikawa</surname><given-names>E</given-names></name><name><surname>Sakuma</surname><given-names>M</given-names></name><name><surname>Hara</surname><given-names>H</given-names></name><name><surname>Ogata</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mincle is an ITAM-coupled activating receptor that senses damaged cells</article-title><source>Nature Immunology</source><volume>9</volume><fpage>1179</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1038/ni.1651</pub-id><pub-id pub-id-type="pmid">18776906</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonekawa</surname><given-names>A</given-names></name><name><surname>Saijo</surname><given-names>S</given-names></name><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Miyake</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>E</given-names></name><name><surname>Suzukawa</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Yoneyama</surname><given-names>M</given-names></name><name><surname>Oh-Hora</surname><given-names>M</given-names></name><name><surname>Akashi</surname><given-names>K</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of mycobacteria</article-title><source>Immunity</source><volume>41</volume><fpage>402</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.08.005</pub-id><pub-id pub-id-type="pmid">25176311</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72923.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Stallings</surname><given-names>Christina L</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Washington University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.08.17.456702" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.17.456702"/></front-stub><body><p>The effect of helminth infection on vaccination against tuberculosis infection and disease is an important area of study. In this manuscript, the authors build off of a large body of prior data showing that mycobacterial antigens upregulate MINCLE whilst the cytokine IL-4 downregulates MINCLE, and as IL-4 is upregulated during Helminth infections, this can antagonize Th1/Th17 responses. By using two different models of helminth infection, the authors demonstrate compelling organ-specific impairment of Th17 responses in a vaccination setting with a MINCLE-dependent adjuvant. The work is topical, may have important translational implications for patients with tuberculosis and helminth co-infections and/or vaccination regimens for patients with helminth infections, and will be of interest to individuals studying the convergence of different infectious diseases.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72923.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Stallings</surname><given-names>Christina L</given-names></name><role>Reviewing Editor</role><aff><institution>Washington University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.17.456702">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.08.17.456702v1.full">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;IL-4 and helminth infection downregulate MINCLE-dependent macrophage response to mycobacteria and Th17 adjuvanticity&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Bavesh Kana as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The authors conclude that the organ-specific effects on the Th17 vaccination response in the helminth infection setting are mediated by IL-4 (see, for instance, abstract, l. 48), tying together the different parts of the manuscript. The authors should provide further evidence for a direct contribution of IL-4 to the thwarted Th17 response to MINCLE-dependent immunization in these helminth models. For instance, interference with IL-4 secretion (e.g. by IL-4 blockade) would markedly strengthen the impact of the manuscript.</p><p>2) The kinetics of the IL-4-mediated effects on MINCLE expression and function would be helpful to understand the biological implications. For instance, in the in vitro studies, have the authors performed IL-4 treatment at different time points (e.g. pre-incubation)?</p><p>3) In Figure 1, the authors observed that a similar pattern of induced expression and regulation by IL-4 as for MINCLE was observed for the CLRs DECTIN-2 and MCL as well. Have the authors elaborated on this finding more in depth? Why did the authors focus exclusively on MINCLE?</p><p>4) It would be interesting for the authors to add some discussion as to why the IL-4-induced downregulation of Mincle was not observed in neutrophils.</p><p>5) For Figure 3E, did the authors examine the cytokine production from lymphnode cells or splenocytes upon re-stimulation with mycobacterial antigens?</p><p>6) Line 173- all data should be shown, especially early timepoints in this case since 24 hours is too late to measure phagocytosis. An even earlier time point than 6 hours would also be beneficial.</p><p>7) Figure 3 and Lines 203-204- The differences in eosinophils is very obvious, but since all cell types are shown as frequencies, the reduced frequency of monocytes/macrophages could be due to the increased eosinophils. In order to make any conclusions about the number of macrophages/monocytes, total cell numbers must be provided and compared.</p><p>8) Line 177- It is possible that the MINCLE deficient macrophages have a defect in phagocytosis that leads to lower levels of TNF and G-CSF. The authors should present phagocytosis and bacterial burden data for the Mincle-/- macrophages to be able to discuss a potential role (or lack thereof) for bacterial number.</p><p>9) In the material and methods, the authors mention the BCG MOI as &quot;indicated in figure &quot; but did not provide the MOI in figure 1 A-D.</p><p>10) Figure 3 claims to address: &quot;Co-infection with N.brasiliensis (hookworm) impairs MINCLE upregulations on peritoneal monocytes but does not reduce phagocytosis during BCG infection&quot;, but Figure 3 does not test phagocytosis.</p><p>11) Figure 3D and E would benefit with an N.b. control to see how just the helminth infection affects cell populations.</p><p>12) The graphs in figure 4 (i.e. 4B) look like they should be on a log scale. On the linear scale, the higher points completely wash out any difference in the lower points. Also be sure to mention the limit of detection, were these all above it? This comment also applies to similar panels in Figure 5.</p><p>13) The authors repeatedly claim to be measuring &quot;T cell response&quot;, but they never isolate T cells and the experiments were performed with total splenocyte or total lymph node cells.</p><p>14) In the figures, the authors should specify H1/CAF and H1/CpG, instead of both being a common H1 designation. i.e. 4A-D: H1/CAF and E,F: H1/CpG.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.72923.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors conclude that the organ-specific effects on the Th17 vaccination response in the helminth infection setting are mediated by IL-4 (see, for instance, abstract, l. 48), tying together the different parts of the manuscript. The authors should provide further evidence for a direct contribution of IL-4 to the thwarted Th17 response to MINCLE-dependent immunization in these helminth models. For instance, interference with IL-4 secretion (e.g. by IL-4 blockade) would markedly strengthen the impact of the manuscript.</p></disp-quote><p>We thank the Reviewers for this suggestion to test a causal role of IL-4 in the inhibition of the Th17 response.</p><p>As an alternative strategy to investigate whether IL-4 directly contributes to inhibition of the Th17 immune response in vivo we employed mice deficient in both Il4 and Il13 genes (designated 4-13ko mice). We chose this genetic tool because we have previously found that both IL-4 and IL-13 down-regulate MINCLE expression on macrophages in vitro through STAT6 signaling (Hupfer et al. 2016 Front Immunol) and both cytokines are expressed during helminth infection.</p><p>Following immunization with the MINCLE-dependent adjuvant CAF01, the reduced production of IFNγ and IL-17 found in splenocytes of C57BL/6 mice with concurrent infection with N. brasiliensis was restored in the 4-13ko mice. Thus, IL-4 and/or IL-13 are causally linked to the loss of Th1/Th17 adjuvanticity in mice with underlying helminth infection.</p><p>These new data are shown in new Figure 6 and in the Results section (lines 307-319) in the revised manuscript, including the results for IL-10 (lower in infected 4-13ko mice) and IL-4 (as expected not produced in 4-13ko mice). These findings are also described in the Abstract (lines 49-52) and are interpreted in the Discussion section (lines 370-375; lines 414-417).</p><disp-quote content-type="editor-comment"><p>2) The kinetics of the IL-4-mediated effects on MINCLE expression and function would be helpful to understand the biological implications. For instance, in the in vitro studies, have the authors performed IL-4 treatment at different time points (e.g. pre-incubation)?</p></disp-quote><p>The Reviewers’ comment raises an interesting question because in vivo the timing of stimulation of APC with the MINCLE-triggering adjuvant may be after, concomitantly or before being exposed to IL-4. However, in all in vitro experiments performed for this manuscript, we did add the IL-4 at the time of stimulating the macrophages with BCG or LPS. On the other hand, the down-regulation of MINCLE on monocytes in vivo by IL-4 via minicircle DNA injection constitutes a pre-exposure setting. Therefore, it appears that concomitant exposre to and pre-incubation with IL-4 have comparable effects.</p><disp-quote content-type="editor-comment"><p>3) In Figure 1, the authors observed that a similar pattern of induced expression and regulation by IL-4 as for MINCLE was observed for the CLRs DECTIN-2 and MCL as well. Have the authors elaborated on this finding more in depth? Why did the authors focus exclusively on MINCLE?</p></disp-quote><p>There are two reasons for focusing on MINCLE in this manuscript: first, it showed the strongest inducibility by stimulation with TDB or BCG, and, second, the in vivo immunization experiments were done using the MINCLE-dependent adjuvant CAF01 (Figures 4 and 5). However, we agree with the Reviewers that the regulation of DECTIN-2 and MCL, and also of DECTIN-1, by IL-4 are also interesting.</p><p>Therefore, we have performed flow cytometry to validate the mRNA expression data shown in Figure 1B and D for DECTIN-2 and for DECTIN-1. Unfortunately, MCL protein levels could not be investigated because we could not get our hands on a suitable antibody.</p><p>The new data we obtained confirm at the cell surface protein level the upregulation of DECTIN-2 after stimulation with BCG and its inhibition by IL-4. In addition, these data also show that IL-4 alone induces DECTIN-1 upregulation at the protein level; however, stimulation with BCG led to downregulation of DECTIN-1 at the cell surface, contrary to what was observed at the mRNA level (Figure 1D). These new data are included as new Figure 1F and 1G and described in the Results section (lines 171-175) of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>4) It would be interesting for the authors to add some discussion as to why the IL-4-induced downregulation of Mincle was not observed in neutrophils.</p></disp-quote><p>This is an interesting and difficult question. Perhaps neutrophils are less transcriptionally responsive compared to monocytes/macrophages because of their short life span. Definitely, it would be very interesting to compare side-by-side the response to IL-4 between neutrophils and macrophages in a future experiment. We have commented on this point in the Discussion (lines 335-337).</p><disp-quote content-type="editor-comment"><p>5) For Figure 3E, did the authors examine the cytokine production from lymphnode cells or splenocytes upon re-stimulation with mycobacterial antigens?</p></disp-quote><p>Figure 3E shows the expression of MINCLE on peritoneal monocytes and neutrophils. Therefore, we assume that the question is in fact directed at Figure 4E/F, where cell suspensions from lymph nodes or spleens were re-stimulated with anti-CD3 antibody or the fusion protein H1 in vitro. In fact, H1 is a fusion of two proteins from <italic>M. tuberculosis</italic> (Ag85B and ESAT-6), thus, we did exactly what the Reviewers are asking for.</p><disp-quote content-type="editor-comment"><p>6) Line 173- all data should be shown, especially early timepoints in this case since 24 hours is too late to measure phagocytosis. An even earlier time point than 6 hours would also be beneficial.</p></disp-quote><p>As requested by the Reviewers, we include now the phagocytosis data for the 6 hour timepoint, that were mentioned before as data not shown, in Figure 2A. The histograms and quantitation look very similar to what was already depicted for the 24 hour timepoint. We have not performed phagocytosis assays at earlier timepoints for IL-4-treated macrophages because any changes that may occur in phagocytosis capacity in the period before 6 hours will be transient given the absence of an IL-4 effect after 6 and 24 hours, and we do not think that such transient effects would be functionally relevant in terms of the impact of IL-4 on the cytokine response to BCG that is analyzed in Figure 2, too.</p><p>Comment (8) below addresses a related topic, namely the question whether phagocytosis is dependent on Mincle or the adapter protein FcRγ. This question is relevant because we have used BMM deficient in these proteins as comparison to IL-4-treatment and the impact on cytokine production in Figure 2. Indeed, we have determined phagocytosis in assays using BMM from Mincle<sup>-/-</sup> and Fcer1g<sup>-/-</sup> mice that showed no alterations in the uptake of BCG. These results are now included as new Figure 2C.</p><disp-quote content-type="editor-comment"><p>7) Figure 3 and Lines 203-204- The differences in eosinophils is very obvious, but since all cell types are shown as frequencies, the reduced frequency of monocytes/macrophages could be due to the increased eosinophils. In order to make any conclusions about the number of macrophages/monocytes, total cell numbers must be provided and compared.</p></disp-quote><p>We agree that no statement can be made here about the numbers of macrophages or monocytes. In fact, our intention here was primarily to examine the impact of helminth infection on the expression of MINCLE on these cells. Therefore, we did not regularly count the absolute numbers of peritoneal cells. However, in the two experiments when cells were counted, there was no difference in total peritoneal exudate cell numbers between the conditions “BCG alone” and “BCG+N. brasiliensis”.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-72923-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>8) Line 177- It is possible that the MINCLE deficient macrophages have a defect in phagocytosis that leads to lower levels of TNF and G-CSF. The authors should present phagocytosis and bacterial burden data for the Mincle-/- macrophages to be able to discuss a potential role (or lack thereof) for bacterial number.</p></disp-quote><p>The question whether phagocytosis is dependent on Mincle or the adapter protein FcRγ is relevant because we have used BMM deficient in these proteins as comparison to IL-4-treatment and the impact on cytokine production in Figure 2. Indeed, we have determined phagocytosis in assays using BMM from Mincle<sup>-/-</sup> and Fcer1g<sup>-/-</sup> mice that showed no alterations in the uptake of BCG. These results are now included as new Figure 2C in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>9) In the material and methods, the authors mention the BCG MOI as &quot;indicated in figure &quot; but did not provide the MOI in figure 1 A-D.</p></disp-quote><p>This information (MOI 10) is now given in the legend to Figure 1.</p><disp-quote content-type="editor-comment"><p>10) Figure 3 claims to address: &quot;Co-infection with N.brasiliensis (hookworm) impairs MINCLE upregulations on peritoneal monocytes but does not reduce phagocytosis during BCG infection&quot;, but Figure 3 does not test phagocytosis.</p></disp-quote><p>The impact of infection with N. brasiliensis on phagocytosis of BCG in vivo was determined by flow cytometry of peritoneal lavage cells harvested 24 hours after infection with BCG-DsRed. As shown in Figure 3F, the percentages of BCG-containing monocytes were comparable in mice with underlying helminth infection and controls.</p><disp-quote content-type="editor-comment"><p>11) Figure 3D and E would benefit with an N.b. control to see how just the helminth infection affects cell populations.</p></disp-quote><p>N. brasiliensis infection without injection of BCG was only included in one of the experiments with two mice. Given this low number of replicates, we decided not to include the data in Figure 3 D+E. As expected the data from this single experiment showed a dominance of eosinophils in the peritoneum of mice infected with N. brasiliensis.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-72923-sa2-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>12) The graphs in figure 4 (i.e. 4B) look like they should be on a log scale. On the linear scale, the higher points completely wash out any difference in the lower points. Also be sure to mention the limit of detection, were these all above it? This comment also applies to similar panels in Figure 5.</p></disp-quote><p>We also considered the question how best to scale the y-axis. Finally, we decided to keep the linear scale. The low values were close to the limit of detection; these are now depicted in the graphs of Figures 4, 5 and 6, or stated in the Figure legends. The distribution of the data is quite wide; however, the statistical testing and average values demonstrate that significant differences can be observed in helminth-infected mice compared to controls.</p><disp-quote content-type="editor-comment"><p>13) The authors repeatedly claim to be measuring &quot;T cell response&quot;, but they never isolate T cells and the experiments were performed with total splenocyte or total lymph node cells.</p></disp-quote><p>The Reviewers correctly point out we do not show in vitro restimulations with isolated T cells or perform intracellular cytokine stainings to demonstrate T cells are the source of the cytokines measured in the supernatants of lymph node and spleen cells after re-stimulation with H1 or anti-CD3 (Figure 4 and Figure 5). We have addressed this question in earlier work published in 2013, showing that IFNγ and IL-17 are detectable by ICS mostly in CD4<sup>+</sup> T cells (Desel C et al. PLoS ONE 8: e53531, doi:10.1371/journal.pone.0053531, Supplemental Figure S1). This paper is cited in the manuscript as reference 51 (line 238). The group of Peter Andersen has published several papers comprehensively analyzing the antigen-specific T cell response using exactly the same antigen-adjuvant combination as in this manuscript. Their data demonstrate the development of multifunctional antigen-specific CD4<sup>+</sup> T cells producing IFNγ, IL-2, and TNF (Lindenstrom T et al. J Immunol 182: 8047. doi.org/10.4049/jimmunol.0801592); in a recent publication combining the CAF01 formulation with a Chlamydia vaccine, the antigen-specific production of IL-17 by CD4<sup>+</sup> T cells was demonstrated by ICS (Nguyen N et al. NPJ Vaccines 5: 7. doi: 10.1038/s41541-020-0157-x. eCollection 2020). Thus, our notion that the cytokines secreted during the re-stimulation assays in vitro are T cell-derived is based on published data from several groups for IFNγ and IL-17. These papers are now cited in the Results section (lines 235-239).</p><disp-quote content-type="editor-comment"><p>14) In the figures, the authors should specify H1/CAF and H1/CpG, instead of both being a common H1 designation. i.e. 4A-D: H1/CAF and E,F: H1/CpG.</p></disp-quote><p>The use of the different adjuvants CAF01 or CpG or G3D6A is now indicated on the respective panels in Figures 4 and 5, as suggested by the Reviewers.</p></body></sub-article></article>